<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults - Molano Franco, D - 2019 | Cochrane Library</title> <meta content="Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults - Molano Franco, D - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011811.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults - Molano Franco, D - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011811.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011811.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults" name="citation_title"/> <meta content="Daniel Molano Franco" name="citation_author"/> <meta content="Fundacion Universitaria de Ciencias de la Salud, Hospital de San José" name="citation_author_institution"/> <meta content="Ingrid Arevalo‐Rodriguez" name="citation_author"/> <meta content="inarev7@yahoo.com" name="citation_author_email"/> <meta content="Marta Roqué i Figuls" name="citation_author"/> <meta content="CIBER Epidemiología y Salud Pública (CIBERESP)" name="citation_author_institution"/> <meta content="Nadia G Montero Oleas" name="citation_author"/> <meta content="Centro de Investigación de Salud Pública y Epidemiología Clínica (CISPEC). Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE" name="citation_author_institution"/> <meta content="Xavier Nuvials" name="citation_author"/> <meta content="Javier Zamora" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD011811.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011811.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011811.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011811.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Biomarkers [blood]; Critical Illness; Diagnosis, Differential; Interleukin‐6 [*blood]; Sepsis [*diagnosis]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011811.pub2&amp;doi=10.1002/14651858.CD011811.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6iOnQIUh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011811\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011811\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011811.pub2",title:"Plasma interleukin\\u20106 concentration for the diagnosis of sepsis in critically ill adults",firstPublishedDate:"Apr 30, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Emergency and Critical Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011811.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011811.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011811.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011811.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011811.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011811.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011811.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011811.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011811.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011811.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6164 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011811.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0073"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0038"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0040"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/appendices#CD011811-sec-0078"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/table_n/CD011811StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/table_n/CD011811StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0002">Daniel Molano Franco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Ingrid Arevalo‐Rodriguez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0004">Marta Roqué i Figuls</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0005">Nadia G Montero Oleas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0006">Xavier Nuvials</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information#CD011811-cr-0007">Javier Zamora</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information/en#CD011811-sec-0092">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011811.pub2">https://doi.org/10.1002/14651858.CD011811.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011811-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011811-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011811-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011811-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011811-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011811-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011811-abs-0001" lang="en"> <section id="CD011811-sec-0001"> <h3 class="title" id="CD011811-sec-0001">Background</h3> <p>The definition of sepsis has evolved over time, along with the clinical and scientific knowledge behind it. For years, sepsis was defined as a systemic inflammatory response syndrome (SIRS) in the presence of a documented or suspected infection. At present, sepsis is defined as a life‐threatening organ dysfunction resulting from a dysregulated host response to infection. Even though sepsis is one of the leading causes of mortality in critically ill patients, and the World Health Organization (WHO) recognizes it as a healthcare priority, it still lacks an accurate diagnostic test. Determining the accuracy of interleukin‐6 (IL‐6) concentrations in plasma, which is proposed as a new biomarker for the diagnosis of sepsis, might be helpful to provide adequate and timely management of critically ill patients, and thus reduce the morbidity and mortality associated with this condition. </p> </section> <section id="CD011811-sec-0002"> <h3 class="title" id="CD011811-sec-0002">Objectives</h3> <p>To determine the diagnostic accuracy of plasma interleukin‐6 (IL‐6) concentration for the diagnosis of bacterial sepsis in critically ill adults. </p> </section> <section id="CD011811-sec-0003"> <h3 class="title" id="CD011811-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, LILACS, and Web of Science on 25 January 2019. We screened references in the included studies to identify additional studies. We did not apply any language restriction to the electronic searches. </p> </section> <section id="CD011811-sec-0004"> <h3 class="title" id="CD011811-sec-0004">Selection criteria</h3> <p>We included diagnostic accuracy studies enrolling critically ill adults aged 18 years or older under suspicion of sepsis during their hospitalization, where IL‐6 concentrations were evaluated by serological measurement. </p> </section> <section id="CD011811-sec-0005"> <h3 class="title" id="CD011811-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the references to identify relevant studies and extracted data. We assessed the methodological quality of studies using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2) tool. We estimated a summary receiver operating characteristic (SROC) curve by fitting a hierarchical summary ROC (HSROC) non‐linear mixed model. We explored sources of heterogeneity using the HSROC model parameters. We conducted all analyses in the SAS statistical software package and R software. </p> </section> <section id="CD011811-sec-0006"> <h3 class="title" id="CD011811-sec-0006">Main results</h3> <p>We included 23 studies (n = 4192) assessing the accuracy of IL‐6 for the diagnosis of sepsis in critically ill adults. Twenty studies that were available as conference proceedings only are awaiting classification. The included participants were heterogeneous in terms of their distribution of age, gender, main diagnosis, setting, country, positivity threshold, sepsis criteria, year of publication, and origin of infection, among other factors. Prevalence of sepsis greatly varied across studies, ranging from 12% to 78%. We considered all studies to be at high risk of bias due to issues related to the index test domain in QUADAS‐2. The SROC curve showed a great dispersion in individual studies accuracy estimates (21 studies, 3650 adult patients), therefore the considerable heterogeneity in the collected data prevented us from calculating formal accuracy estimates. Using a fixed prevalence of sepsis of 50% and a fixed specificity of 74%, we found a sensitivity of 66% (95% confidence interval 60 to 72). If we test a cohort 1000 adult patients under suspicion of sepsis with IL‐6, we will find that 330 patients would receive appropriate and timely antibiotic therapy, while 130 patients would be wrongly considered to have sepsis. In addition, 370 out of 1000 patients would avoid unnecessary antibiotic therapy, and 170 patients would have been undiagnosed of sepsis. This numerical approach should be interpreted with caution due to the limitations described above. </p> </section> <section id="CD011811-sec-0007"> <h3 class="title" id="CD011811-sec-0007">Authors' conclusions</h3> <p>Our evidence assessment of plasma interleukin‐6 concentrations for the diagnosis of sepsis in critically ill adults reveals several limitations. High heterogeneity of collected evidence regarding the main diagnosis, setting, country, positivity threshold, sepsis criteria, year of publication, and the origin of infection, among other factors, along with the potential number of misclassifications, remain significant constraints for its implementation. The 20 conference proceedings assessed as studies awaiting classification may alter the conclusions of the review once they are fully published and evaluated. Further studies about the accuracy of interleukin‐6 for the diagnosis of sepsis in adults that apply rigorous methodology for conducting diagnostic test accuracy studies are needed. The conclusions of the review will likely change once the 20 studies pending publication are fully published and included. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011811-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011811-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011811-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011811-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011811-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011811-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011811-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011811-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011811-abs-0005" lang="en"> <h3>Levels of interleukin‐6 in identifying severely ill adult patients with sepsis</h3> <p><b>Review question</b> </p> <p>We evaluated the evidence on the ability of interleukin‐6 (IL‐6) levels in plasma to identify adult patients with sepsis. Interleukin‐6 is a cytokine (a broad and loose category of small proteins) secreted by immune cells that mediates a wide range of biological activities. </p> <p><b>Background</b> </p> <p>Sepsis is a potentially life‐threatening response by the immune system to an infection that can result in tissue damage, organ failure, and even death, and should be considered as a medical emergency. About 288 septic cases by 100,000 person‐years occur in hospital settings, and 17% of those patients could die. Early identification of patients having sepsis is the first step for immediate medical management, which is essential to avoid further complications and death. Treatment consists mainly of the use of antibiotics (a drug that inhibits the growth of dangerous micro‐organisms). Several tools have been proposed for sepsis diagnosis, as well as the physical examination of blood cultures (the assessment of blood samples to identify micro‐organisms causing the infection). Interleukin‐6 is a molecule that helps in the communication of cells during the body's response to an infection. It has been suggested that the measurement of levels of IL‐6 in the plasma from blood samples during the onset of sepsis can be helpful in identifying sepsis patients early and initiating adequate treatment. </p> <p><b>Study characteristics</b> </p> <p>We performed a thorough literature search for studies reporting the use of IL‐6 levels for detection of sepsis up to January 2019. We found 23 studies enrolling 4192 severely ill adults. </p> <p><b>Key results</b> </p> <p>Our assessment of the evidence reveals the complexity of the research topic, represented in the high variability of information reported by the studies. We found the characteristics of assessed patients to vary considerably between studies in terms of age, gender, setting, initial diagnosis, indicative value for sepsis, and source of infection, among other factors. This variability in the collected data prevented a formal numerical synthesis of the findings. Using the available data to perform an approximated estimation of the consequences, we found that 700 out of 1000 patients under suspicion of sepsis might be correctly classified, but 130 out of 1000 patients would be wrongly considered as having sepsis, while 170 out of 1000 patients might be incorrectly considered as not having sepsis. These errors would result in a serious increase in the risk of further morbidity and death due to delays of adequate treatment. This information should be interpreted with caution due to limitations in the collected data. </p> <p><b>Quality of the evidence</b> </p> <p>We judged the included studies to have important limitations in their validity, hence they are at high risk of providing distorted results (i.e. to be at high risk of bias). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011811-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011811-sec-0073"></div> <h3 class="title" id="CD011811-sec-0074">Implications for practice</h3> <section id="CD011811-sec-0074"> <p>Our evidence assessment of plasma interleukin‐6 concentrations for the diagnosis of sepsis in critically ill adults reveals several limitations. High heterogeneity of the collected evidence regarding the main diagnosis, setting, country, positivity threshold, sepsis criteria, year of publication, and origin of infection, among other factors, along with the potential number of misclassifications, remain significant constraints for its implementation. The 20 conference proceedings assessed as studies awaiting classification may alter the conclusions of the review once they are fully published and evaluated. </p> </section> <h3 class="title" id="CD011811-sec-0075">Implications for research</h3> <section id="CD011811-sec-0075"> <p>Further studies about the accuracy of interleukin‐6 for diagnosis of sepsis in adult patients are needed. These studies should follow well‐known methodologies for the performance of diagnostic test accuracy (DTA) studies, including: </p> <p> <ul id="CD011811-list-0006"> <li> <p>the predefinition of a range of thresholds to test positivity of this biomarker;</p> </li> <li> <p>adherence to recognized guidelines for reporting of DTA studies, such as the Standards for Reporting of Diagnostic Accuracy Studies (STARD) initiative (<a href="http://.equator-network.org/reporting-guidelines/stard/" target="_blank">equator‐network.org/reporting‐guidelines/stard/</a>); </p> </li> <li> <p>exploration of the diagnostic value of interleukin‐6 concentrations added to other biomarkers, or as a part of a diagnostic algorithm; </p> </li> <li> <p>in addition, we suggest that future studies adopt the current definitions and clinical criteria recommended by Singer and colleagues in order to improve the accuracy of research in this field (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011811-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011811-sec-0029"></div> <div class="table" id="CD011811-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Plasma interleukin‐6 concentration for diagnosis of sepsis in critically ill adults</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Critically ill adults under suspicion of sepsis (i.e. with SIRS symptoms)</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Prior testing</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Physical examination and history</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Index test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Plasma interleukin‐6, measured before antibiotic treatment. Cut‐off for positivity ranged from 40 to 200,000 pg/mL. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Role of the test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Triage: First test for patients with SIRS symptoms and waiting for further results (i.e. culture) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Intensive care units, emergency departments, institutional setting (no details provided)</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>3 sepsis definitions derived from expert consensus were considered valid reference standards: </p> <p> <ul id="CD011811-list-0001"> <li> <p>1991 ACCP/SCCM Consensus Conference (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>); </p> </li> <li> <p>2001 SCCM/ESICM/ACCP/ATS/SIS consensus (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>); </p> </li> <li> <p>2015 ESICM/SCCM consensus (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> </li> </ul> </p> <p>Sepsis criteria were applied by critical care, emergency, or internal medicine clinicians.</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Index test</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Prevalence</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (under fixed specificity)<sup>1</sup> </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (fixed)<sup>2</sup> </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of false positives out of 1000 patients</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of false negatives out of 1000 patients</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Plasma interleukin‐6 concentration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>3650</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>66% (95% confidence interval 60 to 72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>74%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>229</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>High heterogeneity of collected evidence remains a significant constraint for plasma interleukin‐6 implementation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>HSROC (hierarchical summary receiver operating characteristic) parameters were used to illustrate sensitivity for a fixed specificity.<br/> <sup>2</sup>Median specificity estimated from included studies. </p> <p><b>Abbreviations: AB</b> : antibiotic; <b>ACCP</b> : American College of Chest Physicians; <b>ATS</b> : American Thoracic Society; <b>ESICM</b> : European Society of Intensive Care Medicine; <b>QUADAS</b> : Quality Assessment of Diagnostic Accuracy Studies; <b>SCCM</b> : Society of Critical Care Medicine; <b>SIRS</b> : systemic inflammatory response syndrome; <b>SIS</b>: Surgical Infection Society. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011811-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011811-sec-0030"></div> <p>The diagnosis of sepsis in critically ill patients with non‐specific findings of an acute inflammatory process can be challenging (<a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>). In a significant number of cases, the diagnosis of sepsis becomes clear after completing the patient medical history and physical examination. However, in other circumstances, including comatose, elderly, or pregnant patients, the diagnosis of sepsis remains difficult (<a href="./references#CD011811-bbs2-0109" title="AbrahamE , MatthayMA , DinarelloCA , VincentJL , CohenJ , OpalSM , et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Critical Care Medicine2000;28(1):232‐5. [PUBMED: 10667529] ">Abraham 2000</a>). Currently, the diagnosis of sepsis is based on clinical findings and the presence of organ dysfunction (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). Several new biological indicators (biomarkers) have been proposed for the diagnosis of sepsis, but no single one of them has gained unanimous acceptance (<a href="./references#CD011811-bbs2-0159" title="RelloJ , Valenzuela‐SanchezF , Ruiz‐RodriguezM , MoyanoS . Sepsis: a review of advances in management. Advances in Therapy2017;34(11):2393‐411. [PUBMED: 29022217] ">Rello 2017</a>; <a href="./references#CD011811-bbs2-0177" title="vanEngelenTSR , WiersingaWJ , SciclunaBP , van derPollT . Biomarkers in sepsis. Critical Care Clinics2018;34(1):139‐52. [PUBMED: 29149935] ">van Engelen 2018</a>). </p> <section id="CD011811-sec-0031"> <h3 class="title" id="CD011811-sec-0031">Target condition being diagnosed</h3> <p>The clinical understanding of sepsis has evolved over the years. For several years, sepsis was defined as a systemic inflammatory response syndrome (SIRS) in the presence of a documented or suspected infection (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>; <a href="./references#CD011811-bbs2-0167" title="Shankar‐HariM , DeutschmanCS , SingerM . Do we need a new definition of sepsis?. Intensive Care Medicine2015;41(5):909‐11. [PUBMED: 25643905] ">Shankar‐Hari 2015</a>). In 2001, the Society of Critical Care Medicine (SCCM), the European Society of Intensive Care Medicine (ESICM), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the Surgical Infection Society (SIS) stated that SIRS involves changes, by unknown causes, of clinical baseline parameters such as body temperature, hypothermia, heart rate, respiratory rate, and white blood cell count, among others (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>; <a href="./references#CD011811-bbs2-0156" title="Rangel‐FraustoMS , PittetD , CostiganM , HwangT , DavisCS , WenzelRP . The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA1995;273(2):117‐23. [PUBMED: 7799491] ">Rangel‐Frausto 1995</a>). Under these criteria, in patients with symptoms of sepsis, the attending physician used the term 'clinically suspected infection' to indicate the suspicion of an ongoing infection, followed by the prescription of immediate initiation of antimicrobial therapy and submission of a request for a complete set of tests to determine the presence or absence of an infection (<a href="./references#CD011811-bbs2-0156" title="Rangel‐FraustoMS , PittetD , CostiganM , HwangT , DavisCS , WenzelRP . The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA1995;273(2):117‐23. [PUBMED: 7799491] ">Rangel‐Frausto 1995</a>). </p> <p>In 2015, a consensus task force of the ESICM and the SCCM updated the definition of sepsis and septic shock, which is currently in use (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). At present, sepsis is defined as a life‐threatening organ dysfunction resulting from a dysregulated host response to infection (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). The new definition withdraws the terms 'SIRS' and 'severe sepsis' and instead prioritizes organ dysfunction. Organ dysfunction can be identified as an acute change in the total Sequential Organ Failure Assessment (SOFA) score ≥ 2 points due to infection. A SOFA score ≥ 2 reflects an overall mortality risk of approximately 10% in a general hospital population with suspected infection (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). In addition, septic shock is defined as a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to increase mortality (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). Patients with septic shock can be identified from a clinical construct of sepsis with persisting hypotension requiring vasopressors to maintain blood pressure and hyperlactataemia despite adequate volume resuscitation. Hospital mortality in patients with septic shock has been estimated to be higher than 40% (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> <p>The worldwide burden of sepsis is difficult to estimate due to the variability of settings, designs, and sepsis criteria found in the various studies (<a href="./references#CD011811-bbs2-0130" title="FleischmannC , ScheragA , AdhikariNK , HartogCS , TsaganosT , SchlattmannP , et al. Assessment of global incidence and mortality of hospital‐treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine2016;193(3):259‐72. [PUBMED: 26414292] ">Fleischmann 2016</a>). Based on information from high‐income countries only, Fleischmann and colleagues estimated a population incidence rate of 288 hospital‐treated sepsis cases per 100,000 person‐years, with an increase to 437 cases per 100,000 person‐years in the last 13 years. In addition, an extrapolation of information from the last decade suggests that a total annual number of 31.5 million sepsis and 19.4 million severe sepsis cases are treated worldwide each year, with a case fatality rate of 5.3 million deaths (<a href="./references#CD011811-bbs2-0130" title="FleischmannC , ScheragA , AdhikariNK , HartogCS , TsaganosT , SchlattmannP , et al. Assessment of global incidence and mortality of hospital‐treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine2016;193(3):259‐72. [PUBMED: 26414292] ">Fleischmann 2016</a>). A retrospective cohort study in seven states in the USA identified 192,980 cases of severe sepsis, with an estimated incidence of sepsis of 3 cases per 1000 persons at the population level, and 2.26 cases per 100 hospital discharges; the authors projected an increase in severe sepsis of 1.5% per year (<a href="./references#CD011811-bbs2-0112" title="AngusDC , Linde‐ZwirbleWT , LidickerJ , ClermontG , CarcilloJ , PinskyMR . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine2001;29(7):1303‐10. [PUBMED: 11445675] ">Angus 2001</a>). <a href="./references#CD011811-bbs2-0128" title="FinferS , BellomoR , LipmanJ , FrenchC , DobbG , MyburghJ . Adult‐population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Medicine2004;30(4):589‐96. [PUBMED: 14963646] ">Finfer 2004</a> reported that 11.8 per 100 patients admitted to an intensive care unit (ICU) between 1999 and 2000 were diagnosed with severe sepsis, with an incidence of 0.77 (95% confidence interval (CI) 0.76 to 0.79) per 1000 adult patients. According to <a href="./references#CD011811-bbs2-0140" title="KumarG , KumarN , TanejaA , KaleekalT , TarimaS , McGinleyE , et al. Nationwide trends of severe sepsis in the 21st century (2000‐2007). Chest2011;140(5):1223‐31. [PUBMED: 21852297] ">Kumar 2011</a>, the mortality rate for severe sepsis decreased from 39% to 27% between 2000 and 2007. However, the rates of mortality were higher in people with more organ systems failing. In 2011, the average cost for the treatment of severe sepsis was USD 22,100 per case, with potentially higher expenses depending on patient age, the need for surgical procedures, the presence of organ failure, and variation in costs charged by ICUs (<a href="./references#CD011811-bbs2-0112" title="AngusDC , Linde‐ZwirbleWT , LidickerJ , ClermontG , CarcilloJ , PinskyMR . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine2001;29(7):1303‐10. [PUBMED: 11445675] ">Angus 2001</a>). </p> <p>Sepsis originates as an infection caused by bacteria, fungus, virus, or parasites (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>). One half (52%) of sepsis cases in hospitals in the USA originate from gram‐positive bacteria (<a href="./references#CD011811-bbs2-0128" title="FinferS , BellomoR , LipmanJ , FrenchC , DobbG , MyburghJ . Adult‐population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Medicine2004;30(4):589‐96. [PUBMED: 14963646] ">Finfer 2004</a>). For bacteria to cause infections, they must evade the immune system of the host, either at the site of infection or in the bloodstream. Innate immune cells recognize pathogenic micro‐organisms by sensing common microbial structures known as pathogen‐associated molecular patterns, such as lipoteichoic acid, lipopeptides, lipopolysaccharides, and nucleic acids (<a href="./references#CD011811-bbs2-0119" title="ChristakiE , Giamarellos‐BourboulisEJ . The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence2014;5(1):57‐65. [PUBMED: 24067507] ">Christaki 2014</a>). The first barriers against pathogen invasion are the skin and mucosal surfaces. Neutrophils are the primary and most important cells that defend the host against invading pathogens. Other mechanisms of defence include monocytes and macrophages, cytokines storm, and complement activation. The pathogenesis presents unique features, as they are under the influence of the genetic makeup of the host. (<a href="./references#CD011811-bbs2-0119" title="ChristakiE , Giamarellos‐BourboulisEJ . The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence2014;5(1):57‐65. [PUBMED: 24067507] ">Christaki 2014</a>). </p> <p>A deficient immune system is a risk factor for the development of sepsis, which can be caused by functional asplenia, an infectious disease, or haematologic malignancy (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>). Moreover, malignancy has been associated with an increase in the incidence of sepsis, with a risk ratio of 9.77 (95% CI 9.67 to 9.88) as compared to non‐cancer patients (<a href="./references#CD011811-bbs2-0120" title="DanaiPA , MossM , ManninoDM , MartinGS . The epidemiology of sepsis in patients with malignancy. Chest2006;129(6):1432‐40. [PUBMED: 16778259] ">Danai 2006</a>). Complications associated with the onset of sepsis include acute renal failure, polyneuropathy, cardiomyopathy, and multiple organ dysfunction (<a href="./references#CD011811-bbs2-0141" title="LatronicoN , BoltonCF . Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurology2011;10(10):931‐41. [PUBMED: 21939902] ">Latronico 2011</a>; <a href="./references#CD011811-bbs2-0154" title="PuthuchearyZA , RawalJ , McPhailM , ConnollyB , RatnayakeG , ChanP , et al. Acute skeletal muscle wasting in critical illness. JAMA2013;310(15):1591‐600. [PUBMED: 24108501] ">Puthucheary 2013</a>; <a href="./references#CD011811-bbs2-0164" title="Romero‐BermejoFJ , Ruiz‐BailenM , Gil‐CebrianJ , Huertos‐RanchalMJ . Sepsis‐induced cardiomyopathy. Current Cardiology Reviews2011;7(3):163‐83. [PUBMED: 22758615] ">Romero‐Bermejo 2011</a>). Survivors of sepsis report persistent problems that can last for years after hospital discharge. About 50% to 70% of sepsis survivors report physical alterations (weakness and dyspnoea), psychological problems (post‐traumatic stress syndrome and depression), and cognitive (poor concentration and memory loss) and social issues (delayed return to work and loss of earnings) (<a href="./references#CD011811-bbs2-0126" title="DowdyDW , EidMP , SedrakyanA , Mendez‐TellezPA , PronovostPJ , HerridgeMS , et al. Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Medicine2005;31(5):611‐20. ">Dowdy 2005</a>). Management of septic stages remains a daily challenge for clinicians. Early administration of effective intravenous antimicrobials is highly recommended due to their association with reduced mortality (<a href="./references#CD011811-bbs2-0117" title="Castellanos‐OrtegaA , SuberviolaB , García‐AstudilloLA , HolandaMS , OrtizF , LlorcaJ , et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three‐year follow‐up quasi‐experimental study. Critical Care Medicine2010;38(4):1036‐43. [PUBMED: 20154597] ">Castellanos‐Ortega 2010</a>; <a href="./references#CD011811-bbs2-0127" title="FerrerR , ArtigasA , SuarezD , PalenciaE , LevyMM , ArenzanaA , et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. American Journal of Respiratory and Critical Care Medicine2009;180(9):861‐6. [PUBMED: 19696442] ">Ferrer 2009</a>). </p> </section> <section id="CD011811-sec-0032"> <h3 class="title" id="CD011811-sec-0032">Index test(s)</h3> <p>Interleukin‐6 (IL‐6) is a cytokine secreted by immune cells, such as activated monocytes and macrophages, adipocytes, and endothelial cells, and it mediates a wide range of biological activities (<a href="./references#CD011811-bbs2-0172" title="TanakaT , NarazakiM , KishimotoT . IL‐6 in inflammation, immunity, and disease. Cold Spring Harbor perspectives in biology2014;6(10):a016295. [PUBMED: 25190079] ">Tanaka 2014</a>; <a href="./references#CD011811-bbs2-0175" title="ThompsonDK , HuffmanKM , KrausWE , KrausVB . Critical appraisal of four IL‐6 immunoassays. PLOS ONE2012;7(2):e30659. [PUBMED: 22347395] ">Thompson 2012</a>). Some studies have shown that cytokines such as IL‐1 and tumour necrosis factor (TNF) induce a state of shock with haemodynamic and haematologic alterations, which are classic characteristics of septic stages (<a href="./references#CD011811-bbs2-0116" title="CarsonWE , YuH , DierksheideJ , PfefferK , BouchardP , ClarkR , et al. A fatal cytokine‐induced systemic inflammatory response reveals a critical role for NK cells. Journal of Immunology1999;162(8):4943‐51. [PUBMED: 10202041] ">Carson 1999</a>; <a href="./references#CD011811-bbs2-0125" title="DinarelloCA . Proinflammatory and anti‐inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest1997;112(6 Suppl):321S‐9S. [PUBMED: 9400897] ">Dinarello 1997</a>; <a href="./references#CD011811-bbs2-0135" title="HauptmannB , VanDammeJ , DayerJM . Modulation of IL‐1 inflammatory and immunomodulatory properties by IL‐6. European Cytokine Network1991;2(1):39‐46. [PUBMED: 1651782] ">Hauptmann 1991</a>; <a href="./references#CD011811-bbs2-0176" title="van derPollT , BullerHR , tenCateH , WortelCH , BauerKA , vanDeventerSJ , et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. New England Journal of Medicine1990;322(23):1622‐7. [PUBMED: 2188129] ">van der Poll 1990</a>). Both IL‐6 and IL‐1 play a role in the stimulation of the synthesis of the adrenocorticotropic hormone in the pituitary gland. They induce the synthesis of neuronal growth factor and regulate the growth and development of haematopoietic cells and embryonic stem cells (<a href="./references#CD011811-bbs2-0170" title="SongM , KellumJ . Interleukin‐6. Critical Care Medicine2005;33(12):S463‐5. [PUBMED: 16340422] ">Song 2005</a>). In addition, IL‐6 is an endogenous pyrogen that plays a role in systemic changes associated with infection, tissue injury and in the stimulation of hepatic protein synthesis during acute‐phase responses (<a href="./references#CD011811-bbs2-0139" title="KishimotoT , AkiraS , NarazakiM , TagaT . Interleukin‐6 family of cytokines and gp130. Blood1995;86(4):1243‐54. [PUBMED: 7632928] ">Kishimoto 1995</a>). Interleukin‐6 concentrations can be measured in blood samples at different times during hospitalization (<a href="./references#CD011811-bbs2-0175" title="ThompsonDK , HuffmanKM , KrausWE , KrausVB . Critical appraisal of four IL‐6 immunoassays. PLOS ONE2012;7(2):e30659. [PUBMED: 22347395] ">Thompson 2012</a>); however, IL‐6 measurement in other biological fluids has been suggested as potentially useful for diverse pathological conditions, <a href="./references#CD011811-bbs2-0136" title="HeneyD , WhicherJT . Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement. Annals of Clinical Biochemistry1995;32 (Pt 4):358‐68. [PUBMED: 7486794] ">Heney 1995</a>, including cerebrospinal (<a href="./references#CD011811-bbs2-0074" title="TakahashiW , NakadaT‐a , AbeR , TanakaK , MatsumuraY , OdaS . Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis. Journal of Critical Care2014;29(4):693.e1‐6. [PUBMED: 24636923] ">Takahashi 2014</a>), pleural (<a href="./references#CD011811-bbs2-0174" title="ThomasR , CheahHM , CreaneyJ , TurlachBA , LeeYC . Longitudinal measurement of pleural fluid biochemistry and cytokines in malignant pleural effusions. Chest2016;149(6):1494‐500. [PUBMED: 26836920] ">Thomas 2016</a>), and peritoneal fluids (<a href="./references#CD011811-bbs2-0118" title="CheongYC , SheltonJB , LairdSM , RichmondM , KudesiaG , LiTC , et al. IL‐1, IL‐6 and TNF‐alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Human Reproduction (Oxford, England)2002;17(1):69‐75. [PUBMED: 11756364] ">Cheong 2002</a>). In healthy adults, IL‐6 plasma concentrations range from 0.2 to 7.8 pg/mL, while IL‐6 concentration in adults with sepsis can exceed 1600 pg/mL (<a href="./references#CD011811-bbs2-0175" title="ThompsonDK , HuffmanKM , KrausWE , KrausVB . Critical appraisal of four IL‐6 immunoassays. PLOS ONE2012;7(2):e30659. [PUBMED: 22347395] ">Thompson 2012</a>). Clinical response and the severity of infection affect the values of IL‐6 in adults, but this relationship is not clear in children (<a href="./references#CD011811-bbs2-0111" title="AnejaR , CarcilloJ . Differences between adult and pediatric septic shock. Minerva Anestesiologica2011;77(10):986‐92. [PUBMED: 21952599] ">Aneja 2011</a>). On the contrary, IL‐6 concentrations in newborns have been estimated at between 18 to 26 pg/mL, with a significant decrease during the first few years of life without the presence of infection (<a href="./references#CD011811-bbs2-0170" title="SongM , KellumJ . Interleukin‐6. Critical Care Medicine2005;33(12):S463‐5. [PUBMED: 16340422] ">Song 2005</a>). In addition, some authors have reported elevated concentrations of IL‐6 in paediatric burn patients without sepsis (<a href="./references#CD011811-bbs2-0129" title="FinnertyCC , HerndonDN , JeschkeMG . Inhalation injury in severely burned children does not augment the systemic inflammatory response. Critical Care2007;11(1):R22. [PUBMED: 17306027] ">Finnerty 2007</a>). </p> </section> <section id="CD011811-sec-0033"> <h3 class="title" id="CD011811-sec-0033">Clinical pathway</h3> <p>Since the 2015 sepsis consensus, the underlying organ dysfunction is identified as an acute change in total SOFA score ≥ 2 points due to the infection, and immediate treatment is highly recommended (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). Management of patients with suspected sepsis includes volume resuscitation, a collection of samples for microbiological diagnosis, early antimicrobial therapy, and infection source control (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0161" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine2017;43(3):304‐77. ">Rhodes 2017</a>; <a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). Current clinical practice guidelines recommend administration of empiric antimicrobial therapy, including one or more drugs that have activity against most pathogens (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0134" title="GreenRS , DjogovicD , GrayS , HowesD , BrindleyPG , StenstromR , et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. Canadian Journal of Emergency Medicine2008;10(5):443‐59. [PUBMED: 18826733] ">Green 2008</a>; <a href="./references#CD011811-bbs2-0143" title="LevyMM , EvansLE , RhodesA . The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Medicine2018; Vol. 44, issue 6:925‐8. [PUBMED: 29675566] ">Levy 2018</a>; <a href="./references#CD011811-bbs2-0157" title="ReinhartK , BrunkhorstFM , BoneHG , BardutzkyJ , DempfleCE , ForstH , et al. Prevention, diagnosis, therapy and follow‐up care of sepsis: 1st revision of S‐2k guidelines of the German Sepsis Society (Deutsche Sepsis‐Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv‐ und Notfallmedizin (DIVI)). German Medical Science2010;8:14. [PUBMED: 20628653] ">Reinhart 2010</a>; <a href="./references#CD011811-bbs2-0161" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine2017;43(3):304‐77. ">Rhodes 2017</a>). However, one consequence of this strategy is the overtreatment of patients with non‐infectious diseases, which can induce antimicrobial resistance and increased economic costs. The use of biomarkers for early diagnosis and to guide empiric antimicrobial agents has only been suggested as supplementary data to clinical assessment, in cases of difficult‐to‐culture pathogens, or in clinical situations where the suspected infection is unclear (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0161" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine2017;43(3):304‐77. ">Rhodes 2017</a>). </p> <section id="CD011811-sec-0034"> <h4 class="title">Prior test(s)</h4> <p>No prior tests for the diagnosis of sepsis have been proposed. The basis of future tests, including blood tests and microbiological cultures, lies in the identification of signs of inflammation and/or end‐organ hypoperfusion by a clinical assessment (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0163" title="RizoliSB , MarshallJC . Saturday night fever: finding and controlling the source of sepsis in critical illness. Lancet Infectious Diseases2002;2(3):137‐44. [PUBMED: 11944183] ">Rizoli 2002</a>). </p> </section> <section id="CD011811-sec-0035"> <h4 class="title">Role of index test(s)</h4> <p>At present, sepsis is defined as a suspected or documented infection accompanied by an acute increase of the quick Sequential Organ Failure Assessment (qSOFA) scores (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). For years, cultures have been essential to document the presence of an infection, though their results can take 24 to 48 hours (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>). In addition, the results of the cultures may be undeterminable due to the use of an empiric antimicrobial before the sampling or difficult‐to‐culture pathogens (<a href="./references#CD011811-bbs2-0124" title="DellingerRP , LevyMM , RhodesA , AnnaneD , GerlachH , OpalSM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine2013;41(2):580‐637. [PUBMED: 23353941] ">Dellinger 2013</a>; <a href="./references#CD011811-bbs2-0161" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine2017;43(3):304‐77. ">Rhodes 2017</a>). Biomarkers used for the diagnosis of sepsis may provide faster results in comparison with microbiology tests, resulting in a quicker initiation of treatment (<a href="./references#CD011811-bbs2-0115" title="BoucherBA , HanesSD . Searching for simple outcome markers in sepsis: an effort in futility?. Critical Care Medicine1999;27(7):1390‐1. [PUBMED: 10446842] ">Boucher 1999</a>). Interleukin‐6 appears to be a mediator of sepsis, and its secretion is rapidly induced in the course of acute inflammatory reactions (<a href="./references#CD011811-bbs2-0170" title="SongM , KellumJ . Interleukin‐6. Critical Care Medicine2005;33(12):S463‐5. [PUBMED: 16340422] ">Song 2005</a>). Most patients with sepsis have increased plasma levels of IL‐6 at their admission to the ICU (<a href="./references#CD011811-bbs2-0178" title="WaageA , BrandtzaegP , HalstensenA , KierulfP , EspevikT . The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. Journal of Experimental Medicine1989;169(1):333‐8. [PUBMED: 2783334] ">Waage 1989</a>). High IL‐6 levels have been directly associated with risk of death, especially death caused by intra‐abdominal sepsis (<a href="./references#CD011811-bbs2-0152" title="PatelRT , DeenKI , YoungsD , WarwickJ , KeighleyMR . Interleukin 6 is a prognostic indicator of outcome in severe intra‐abdominal sepsis. British Journal of Surgery1994;81(9):1306‐8. [PUBMED: 7953393] ">Patel 1994</a>). Likewise, an association between mean plasma IL‐6 concentration over time and mortality rate has been shown<b>.</b> Persistent elevation of IL‐6 appears to be more important than that of the initial or peak levels in terms of outcome (<a href="./references#CD011811-bbs2-0153" title="PinskyMR , VincentJL , DeviereJ , AlegreM , KahnRJ , DupontE . Serum cytokine levels in human septic shock. Relation to multiple‐system organ failure and mortality. Chest1993;103(2):565‐75. [PUBMED: 8432155] ">Pinsky 1993</a>). Interleukin‐6 could be considered as a potential triage test of sepsis, in order to ensure quick initiation of empirical antibiotic management in critically ill patients who are waiting for culture results. In addition, if the detection of IL‐6 levels demonstrates high specificity and sensitivity towards sepsis, it might play an important role in replacing other diagnostic tools, thus reducing unnecessary patient exposure to antibiotics (<a href="./references#CD011811-bbs2-0132" title="GentileLF , CuencaAG , VanzantEL , EfronPA , McKinleyB , MooreF , et al. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?. Methods2013;61(1):3‐9. [PUBMED: 23669589] ">Gentile 2013</a>). </p> </section> <section id="CD011811-sec-0036"> <h4 class="title">Alternative test(s)</h4> <p>Currently, several biomarkers that may have the ability to improve early recognition and decrease the severity of sepsis have been evaluated. For example, the use of C‐reactive protein concentrations has been proposed as an acute‐phase reactant for the diagnosis of bacterial infections, as well as a factor that can lead to a reduction in the mortality rate of septic patients (<a href="./references#CD011811-bbs2-0110" title="AndrioloBNG , AndrioloRB , SalomãoR , AtallahÁN . Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010959.pub2] ">Andriolo 2017</a>; <a href="./references#CD011811-bbs2-0150" title="OnyenekwuCP , OkwunduCI , OchodoEA . Procalcitonin, C‐reactive protein, and presepsin for the diagnosis of sepsis in adults and children. Cochrane Database of Systematic Reviews2017, Issue 4. [DOI: 10.1002/14651858.CD012627] ">Onyenekwu 2017</a>; <a href="./references#CD011811-bbs2-0168" title="SimonL , GauvinF , AmreDK , Saint‐LouisP , LacroixJ . Serum procalcitonin and C‐reactive protein levels as markers of bacterial infection: a systematic review and meta‐analysis. Clinical Infectious Diseases2004;39(2):206‐17. [PUBMED: 15307030] ">Simon 2004</a>). A C‐reactive protein level that exceeds 0.8 mg/L is abnormal and may indicate the presence of an inflammatory process. Likewise, the diagnostic value of procalcitonin has been evaluated in several systematic reviews, with contradictory results (<a href="./references#CD011811-bbs2-0168" title="SimonL , GauvinF , AmreDK , Saint‐LouisP , LacroixJ . Serum procalcitonin and C‐reactive protein levels as markers of bacterial infection: a systematic review and meta‐analysis. Clinical Infectious Diseases2004;39(2):206‐17. [PUBMED: 15307030] ">Simon 2004</a>; <a href="./references#CD011811-bbs2-0173" title="TangBM , EslickGD , CraigJC , McLeanAS . Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta‐analysis. Lancet Infectious Diseases2007;7(3):210‐7. [PUBMED: 17317602] ">Tang 2007</a>; <a href="./references#CD011811-bbs2-0179" title="WackerC , PrknoA , BrunkhorstFM , SchlattmannP . Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta‐analysis. Lancet Infectious Diseases2013;13(5):426‐35. [PUBMED: 23375419] ">Wacker 2013</a>). Other biomarkers, such as IL‐ 8, <a href="./references#CD011811-bbs2-0146" title="LivaditiO , KotanidouA , PsarraA , DimopoulouI , SotiropoulouC , AugustatouK , et al. Neutrophil CD64 expression and serum IL‐8: sensitive early markers of severity and outcome in sepsis. Cytokine2006;36(5‐6):283‐90. [PUBMED: 17368039] ">Livaditi 2006</a>, and soluble triggering receptor expressed on myeloid cells 1 (sTREM‐1), <a href="./references#CD011811-bbs2-0131" title="Gamez‐DiazLY , EnriquezLE , MatuteJD , VelasquezS , GomezID , ToroF , et al. Diagnostic accuracy of HMGB‐1, sTREM‐1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. Academic Emergency Medicine2011;18(8):807‐15. [PUBMED: 21762470] ">Gamez‐Diaz 2011</a>, have also been evaluated, without conclusive results (<a href="./references#CD011811-bbs2-0121" title="deMontmollinE , AnnaneD . Year in review 2013: critical care ‐ sepsis. Critical Care2014;18(5):578. [PUBMED: 25673430] ">de Montmollin 2014</a>). </p> </section> </section> <section id="CD011811-sec-0037"> <h3 class="title" id="CD011811-sec-0037">Rationale</h3> <p>Currently, the World Health Organization (WHO) recognizes sepsis as a healthcare priority, and it urges the Member States to include and reinforce the prevention, diagnosis, and treatment of this condition in national health systems (<a href="./references#CD011811-bbs2-0182" title="World Health Organization. Resolution WHA70.7: Improving the prevention, diagnosis and clinical management of sepsis. apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R7‐en.pdf?ua=1&amp;ua=1 (accessed 10 October 2018). ">WHO 2017</a>). Despite the fact that sepsis is one of the leading causes of mortality in critically ill patients, it lacks an accurate diagnostic test (<a href="./references#CD011811-bbs2-0113" title="BloosF , ReinhartK . Rapid diagnosis of sepsis. Virulence2014;5(1):154‐60. [PUBMED: 24335467] ">Bloos 2014</a>). The differentiation of sepsis from other syndromes is essential in order to avoid unnecessary administration of antibiotics and to start appropriate therapy sooner. Some authors have reported higher levels of IL‐6 in patients with sepsis and multiple organ dysfunction, but not in other conditions, such as trauma or cardiac arrest (<a href="./references#CD011811-bbs2-0113" title="BloosF , ReinhartK . Rapid diagnosis of sepsis. Virulence2014;5(1):154‐60. [PUBMED: 24335467] ">Bloos 2014</a>; <a href="./references#CD011811-bbs2-0170" title="SongM , KellumJ . Interleukin‐6. Critical Care Medicine2005;33(12):S463‐5. [PUBMED: 16340422] ">Song 2005</a>). The detection of higher IL‐6 levels could therefore be potentially useful in early diagnosis (<a href="./references#CD011811-bbs2-0138" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] ">Jekarl 2015</a>). Determining the accuracy of the detection of IL‐6 levels as a biomarker for the diagnosis of sepsis might help to provide adequate and timely management of critically ill patients. This could reduce the morbidity and mortality associated with sepsis. Furthermore, an accurate measurement tool may also limit hospitalization costs and potential antimicrobial resistance. This current review focused on one biomarker (IL‐6) only, and did not include comparisons of diagnostic accuracy with other biomarkers, as there is a Cochrane Review in process assessing the roles of C‐reactive protein, procalcitonin, and presepsin as biomarkers for sepsis (<a href="./references#CD011811-bbs2-0150" title="OnyenekwuCP , OkwunduCI , OchodoEA . Procalcitonin, C‐reactive protein, and presepsin for the diagnosis of sepsis in adults and children. Cochrane Database of Systematic Reviews2017, Issue 4. [DOI: 10.1002/14651858.CD012627] ">Onyenekwu 2017</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011811-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011811-sec-0038"></div> <p>To determine the diagnostic accuracy of plasma interleukin‐6 (IL‐6) concentration for the diagnosis of bacterial sepsis in critically ill adults. </p> <section id="CD011811-sec-0039"> <h3 class="title" id="CD011811-sec-0039">Secondary objectives</h3> <p> <ul id="CD011811-list-0002"> <li> <p>To explore the effects of different thresholds in the accuracy of IL‐6 for the diagnosis of sepsis. </p> </li> <li> <p>To determine whether the pathological source of sepsis (i.e. pneumonia, bacteraemia, urinary infections, among others) or other prespecified sources affect the accuracy of plasma IL‐6 concentration as a diagnostic tool. </p> </li> </ul> </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011811-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011811-sec-0040"></div> <section id="CD011811-sec-0041"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011811-sec-0042"> <h4 class="title">Types of studies</h4> <p>We considered diagnostic test accuracy studies that included patients aged 18 years or older with suspicion of sepsis during their hospitalization, and where IL‐6 levels were evaluated by serological measurement, as well as sepsis confirmation by means of clinical diagnosis and/or identification of microbiological pathogens in cultures. Studies should have provided information about the specificity and sensitivity of the results. We considered abstracts and conference proceedings in the initial selection of references. However, due to these selected references not providing enough information for the assessment of the methodological quality, they were classified as studies awaiting classification. We excluded before‐after studies, case‐control studies (see <a href="#CD011811-sec-0096">Differences between protocol and review</a>), and case reports. </p> </section> <section id="CD011811-sec-0043"> <h4 class="title">Participants</h4> <p>We included studies evaluating critically ill adults aged 18 years or older under suspicion of sepsis (i.e. fulfilling SIRS criteria). These studies included participants from different clinical settings, such as emergency departments, hospital wards, and ICUs. We excluded studies of neonatal or paediatric patients with suspicion of sepsis. </p> </section> <section id="CD011811-sec-0044"> <h4 class="title">Index tests</h4> <p>We included articles with a description of the index test for the measurement of IL‐6 in plasma as a sign of systemic inflammatory, metabolic, and physiologic activity. Measurement of IL‐6 concentrations should have been performed before initiation of empirical antibiotic treatment. We excluded measurements of IL‐6 other than serum (i.e. pleural effusion, peritoneal fluid, or cerebrospinal fluid). </p> </section> <section id="CD011811-sec-0045"> <h4 class="title">Target conditions</h4> <p>As we mentioned earlier in the <a href="#CD011811-sec-0030">Background</a> section of this report, for years sepsis was considered to be a systemic inflammatory response syndrome of the host due to an infection (<a href="./appendices#CD011811-sec-0079">Appendix 1</a>) (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>). Recently, a consensus task force of the European Society of Intensive Care Medicine (ESICM) and the Society of Critical Care Medicine (SCCM) updated the definition of sepsis and septic shock to be defined as a life‐threatening organ dysfunction resulting from a dysregulated host response to inflammation (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> </section> <section id="CD011811-sec-0046"> <h4 class="title">Reference standards</h4> <p>The criteria used for the diagnosis of sepsis have been modified from the initial proposals by Bone and colleagues in 1991 (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>), which were endorsed by the American College of Chest Physicians (ACCP) and the SCCM, to those developed in 2015 by the SCCM and the ESICM (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). A full description of the mentioned definitions and clinical criteria can be found in <a href="./appendices#CD011811-sec-0079">Appendix 1</a>, <a href="./appendices#CD011811-sec-0080">Appendix 2</a>, and <a href="./appendices#CD011811-sec-0081">Appendix 3</a>. Briefly, the following three sets of criteria have been used over the years. </p> <p> <ul id="CD011811-list-0003"> <li> <p>1991 ACCP/SCCM criteria (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>): these criteria were the first attempt to provide a conceptual framework to diagnose, monitor, and treat sepsis. In addition, this consensus was the first to introduce the term 'systemic inflammatory response syndrome' (SIRS), broadly defined as all findings associated with systemic activation of the innate immune response. Sepsis is defined under <a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a> as SIRS plus signs of infection, while severe sepsis is considered to be any sepsis associated with organ dysfunction, hypoperfusion, or hypotension. </p> </li> <li> <p>2001 SCCM/ESICM/ACCP/ATS/SIS criteria (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>): the 2001 consensus conference reviewed the strengths and weaknesses of the 1992 criteria, and developed modified criteria incorporating the latest clinical understanding of sepsis, as well as findings of clinical trials. These criteria highlighted the role of systemic inflammation in response to an infection, broadly defined as a pathological process induced by a micro‐organism (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>). Sepsis was then defined as a systemic inflammatory response syndrome of the host due to an infection (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>). </p> </li> <li> <p>2015 SCCM/ESICM criteria (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>): sepsis is defined under <a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a> as a life‐threatening organ dysfunction caused by a dysregulated host response to infection. For clinical cases, organ dysfunction can be defined by an increase in the Sequential Organ Failure Assessment (SOFA) score of 2 points or more. In addition, septic shock is considered as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality. Under <a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>, terms such as SIRS and severe sepsis are no longer recommended in the management of this condition. </p> </li> </ul> </p> <p>A common element to all these criteria is the requisition of cultures to document the suspected infection, however positive findings are not a requirement for antibiotic management (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>; <a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>; <a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). We considered all these criteria as valid reference standards for sepsis, recognizing that the knowledge in this field is still evolving. </p> </section> </section> <section id="CD011811-sec-0047"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011811-sec-0048"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases:</p> <p> <ul id="CD011811-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 1, <a href="./appendices#CD011811-sec-0082">Appendix 4</a>); </p> </li> <li> <p>MEDLINE via Ovid SP (1956 to 25 January 2019, <a href="./appendices#CD011811-sec-0083">Appendix 5</a>); </p> </li> <li> <p>Embase via Ovid SP (1982 to 25 January 2019, <a href="./appendices#CD011811-sec-0084">Appendix 6</a>); </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database) via BIREME (1982 to 25 January 2019, <a href="./appendices#CD011811-sec-0085">Appendix 7</a>); </p> </li> <li> <p>Web of Science Indexes (Science Citation Index Expanded (SCI‐EXPANDED), Social Sciences Citation Index (SSCI), Arts &amp; Humanities Citation Index (A&amp;HCI), Emerging Sources Citation Index (ESCI); from inception to 25 January 2019, <a href="./appendices#CD011811-sec-0086">Appendix 8</a>). </p> </li> </ul> </p> <p>We designed structured search strategies using controlled search terms appropriate for each database as well as free‐text search terms as outlined in the <i>Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy</i> (<a href="./references#CD011811-bbs2-0123" title="DeeksJJ , BossuytPM , GatsonisC (editors) . Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org. ">Deeks 2013</a>). We did not use search filters (collections of terms aimed at reducing the number needed to screen) as an overall limit because in those reviews that have used them they have not proved to be sensitive enough (<a href="./references#CD011811-bbs2-0180" title="WhitingP , WestwoodM , BeynonR , BurkeM , SterneJA , GlanvilleJ . Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology2011;64(6):602‐7. [PUBMED: 21075596] ">Whiting 2011a</a>). We did not apply any language restriction to the electronic searches. </p> </section> <section id="CD011811-sec-0049"> <h4 class="title">Searching other resources</h4> <p>We screened the reference lists of all relevant papers for additional studies and searched for similar articles related to the final included studies. We contacted relevant authors for further details about studies, but we did not receive replies from the contacted authors at the time of review publication (see <a href="#CD011811-sec-0059">Results of the search</a>). We did not perform handsearching, as there is little published evidence of the benefits of handsearching for reports of diagnostic test accuracy studies (<a href="./references#CD011811-bbs2-0133" title="GlanvilleJ , CikaloM , CrawfordF , DozierM , McIntoshH . Handsearching did not yield additional unique FDG‐PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods2012;3(3):202‐13. ">Glanville 2012</a>). </p> </section> </section> <section id="CD011811-sec-0050"> <h3 class="title" id="CD011811-sec-0050">Data collection and analysis</h3> <section id="CD011811-sec-0051"> <h4 class="title">Selection of studies</h4> <p>Two review authors (IAR, DMF) independently identified potentially eligible studies based on title and abstract. Any disagreements were resolved by discussing the paper(s) in question with a third review author (MR). We retrieved the full‐text copy of each study assessed as potentially eligible, and two review authors independently evaluated the full texts for inclusion or exclusion according to the selection criteria. We documented the study selection process in a PRISMA flow diagram. </p> </section> <section id="CD011811-sec-0052"> <h4 class="title">Data extraction and management</h4> <p>Four review authors (DMF, IAR, XN, NM) extracted the study characteristics from each included study, including data on quality assessment and investigation of heterogeneity, and transferred this information into a study‐specific format, as described in <a href="./appendices#CD011811-sec-0087">Appendix 9</a>. Any disagreements were resolved by discussion with a third review author (JZ or MR). We cross‐tabulated the numerical information from the index test results (positive or negative) in 2 x 2 tables against the target disorder (positive or negative), and presented the results in tables (<a href="./appendices#CD011811-sec-0088">Appendix 10</a>). </p> </section> <section id="CD011811-sec-0053"> <h4 class="title">Assessment of methodological quality</h4> <p>Four review authors (NM, JZ, MR, IAR) independently and in duplicate assessed the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2) tool (<a href="./references#CD011811-bbs2-0181" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. [PUBMED: 22007046] ">Whiting 2011b</a>), as recommended by the <i>Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy</i> (<a href="./references#CD011811-bbs2-0123" title="DeeksJJ , BossuytPM , GatsonisC (editors) . Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org. ">Deeks 2013</a>). This tool consists of four domains: patient selection, index test, reference standard, and patient flow. We assessed each domain in terms of risk of bias, and further considered the first three domains in terms of applicability. We reported the QUADAS‐2 methodological assessment of studies using bespoke tables. Operational definitions describing the use of QUADAS‐2 are presented in <a href="./appendices#CD011811-sec-0089">Appendix 11</a>. This format was piloted against 10 primary diagnostic studies in order to standardize this assessment and to identify any possible disagreement between review authors. Any discrepancies were resolved by discussion. </p> </section> <section id="CD011811-sec-0054"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>For all included studies we extracted data from the 2 x 2 tables (numbers of true positives, false positives, true negatives, and false negatives) showing the cross‐classification between binary test results and the binary reference standard. For each study, we calculated sensitivities, specificities and their 95% confidence intervals (CIs) (<a href="./appendices#CD011811-sec-0088">Appendix 10</a>). We presented results graphically by plotting estimates of sensitivities and specificities (both with 95% CIs) in a forest plot and in a receiver operating characteristic (ROC) space in order to visually assess the between‐study variability. We considered these findings in light of the methodological quality of individual studies. We used the Cochrane statistical software Review Manager 5 to document these analyses (<a href="./references#CD011811-bbs2-0160" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>We planned to obtain summary sensitivity and summary specificity estimates using the bivariate model (<a href="./references#CD011811-bbs2-0158" title="ReitsmaJB , GlasAS , RutjesAW , ScholtenRJ , BossuytPM , ZwindermanAH . Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology2005;58(10):982‐90. [PUBMED: 16168343] ">Reitsma 2005</a>), analysing information of the most common thresholds when data with more than one positive threshold was reported within the same study (<a href="./references#CD011811-bbs2-0185" title="Molano FrancoD , Arevalo‐RodriguezI , Roquéi Figuls M , ZamoraJ . Interleukin‐6 for diagnosis of sepsis in critically ill adult patients. Cochrane Database of Systematic Reviews2015, Issue 7. [DOI: 10.1002/14651858.CD011811] ">Molano Franco 2015</a>). However, we were unable to perform this analysis because we observed high heterogeneity in the data that prevented the estimation of summary accuracy estimates. Instead, we estimated a summary ROC (SROC) curve by fitting a hierarchical summary ROC (HSROC) non‐linear mixed model (<a href="./references#CD011811-bbs2-0165" title="RutterCM , GatsonisCA . A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations. Statistics in Medicine2001;20(19):2865‐84. [PUBMED: 11568945] ">Rutter 2001</a>). Using HSROC parameter estimates, we derived sensitivity at the median value of specificity along with corresponding 95% CIs calculated using the delta method as implemented in R package. We calculated the potential numerical consequences given a positive and negative IL‐6 test result, using different prevalences. All analyses were conducted in the SAS statistical software package, <a href="./references#CD011811-bbs2-0166" title="SAS Institute. SAS software. Version 9.4. Cary (NC): SAS Institute, 2014. ">SAS 2014</a>, and R software (<a href="./references#CD011811-bbs2-0155" title="R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2008. ">R Development Core Team 2008</a>). This is a diversion from the protocol that is explained in the <a href="#CD011811-sec-0096">Differences between protocol and review</a> section. </p> </section> <section id="CD011811-sec-0055"> <h4 class="title">Investigations of heterogeneity</h4> <p>We initially investigated heterogeneity by visual examination of forest plots of sensitivities and specificities and through visual examination of individual study results in the ROC space. Anticipated sources of heterogeneity included the year of publication, country/geographical area, setting (emergency, ICUs, hospitalization ward, or other), baseline diagnosis, the origin of infection (pneumonia, urinary infection, meningitis), type of sepsis (severe, septic shock), and type of reference standard. As mentioned above, we estimated an SROC curve by fitting an HSROC (<a href="./references#CD011811-bbs2-0165" title="RutterCM , GatsonisCA . A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations. Statistics in Medicine2001;20(19):2865‐84. [PUBMED: 11568945] ">Rutter 2001</a>), and explored the effect of predefined sources of heterogeneity on model parameters. When possible, we investigated the effect of covariates by including each potential source of heterogeneity, one at each time, in the original HSROC model. We initially explored whether there was a significant difference in the shape of the SROC curve. If we ruled out a significant effect of the covariate on the shape of the curve, we then analysed whether the covariates affected both accuracy and threshold parameters of the model, or either. Conversely, if the shape varies with the covariate, no further simplifications of the model can be performed. We used likelihood ratio tests to compare models with and without the corresponding covariates effects on shape, accuracy and threshold. We conducted all these analyses using the SAS statistical software package (<a href="./references#CD011811-bbs2-0166" title="SAS Institute. SAS software. Version 9.4. Cary (NC): SAS Institute, 2014. ">SAS 2014</a>). This is a diversion from the protocol that is explained in the <a href="#CD011811-sec-0096">Differences between protocol and review</a> section. </p> </section> <section id="CD011811-sec-0056"> <h4 class="title">Sensitivity analyses</h4> <p>We planned to examine the robustness of the meta‐analyses by conducting sensitivity analyses. Our primary analysis included all studies; sensitivity analysis would exclude studies at high risk of bias or studies for which there were important concerns about potential applicability. However, since we judged all included studies as at high risk of bias due to index test issues, this analysis could not be performed. This is a diversion from the protocol that is explained in the <a href="#CD011811-sec-0096">Differences between protocol and review</a> section. </p> </section> <section id="CD011811-sec-0057"> <h4 class="title">Assessment of reporting bias</h4> <p>Quantitative methods for exploring reporting bias are not well established for diagnostic test accuracy studies. We did not perform a formal assessment of publication bias using methods such as funnel plots or regression tests because such techniques have not been useful for diagnostic test accuracy studies (<a href="./references#CD011811-bbs2-0123" title="DeeksJJ , BossuytPM , GatsonisC (editors) . Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org. ">Deeks 2013</a>). This is a diversion from the protocol that is explained in the <a href="#CD011811-sec-0096">Differences between protocol and review</a> section. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011811-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011811-sec-0058"></div> <section id="CD011811-sec-0059"> <h3 class="title" id="CD011811-sec-0059">Results of the search</h3> <p>The details of our search and selection process are shown in <a href="#CD011811-fig-0001">Figure 1</a>. The electronic database searches yielded 41,588 references from selected databases after removal of duplicates. We searched for primary studies through other resources but did not find additional potentially eligible studies. Our initial screening of titles and abstracts identified 108 references to assess in full text. We excluded 65 of the 108 full‐text studies for the following reasons: a) no reporting of accuracy data for IL‐6; b) focus was on the prediction of sepsis; c) case‐control studies; d) other reasons (see <a href="./references#CD011811-sec-0099" title="">Characteristics of excluded studies</a>). We classified 20 conference proceedings that contained insufficient information to apply all of the selection criteria, as well as to perform a full data extraction, as studies awaiting classification (see <a href="./references#CD011811-sec-0100" title="">Characteristics of studies awaiting classification</a>). We included 23 studies in the qualitative synthesis (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). However, because we were unable to rebuild the 2 x 2 table in two studies (we contacted the authors of <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a> and <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a> by email, but at the time of publication of this review had not received replies), we only included 21 studies in the main quantitative analysis (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). In addition, we contacted the main author of <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a> by email to confirm the use of threshold to define sepsis, but at the time of the analysis had not received a reply. We included this study with the reported cut‐off transformed to pg/mL (<a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; 200,000 pg/mL). </p> <div class="figure" id="CD011811-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011811-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <section id="CD011811-sec-0060"> <h4 class="title">Characteristics of included studies</h4> <p>Details of the population, index test, target condition, and reference standard for the 23 included studies are provided in the <a href="./references#CD011811-sec-0098" title="">Characteristics of included studies</a> table. The main characteristics of the included studies are summarized in <a href="#CD011811-tbl-0002">Table 1</a>. </p> <div class="table" id="CD011811-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year of publication</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age (as reported)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b># Male (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>APACHE (as reported)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Origin of infection</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IL‐6 measurement brand</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Use of empirical antibiotics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Funding</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Finland</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 (47.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐acquired bloodstream infection with positive blood cultures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia, urinary tract infection, encephalitis and meningitis, abscesses, sinusitis, malaria, erysipelas </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescent immunoassay system (Immulite; Diagnostic Products, Los Angeles, CA, USA) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 42 (culture‐negative sepsis) vs 53.7 (culture‐positive sepsis) vs 54 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 (58.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture‐negative/positive bacterial sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 15.9 (SIRS) vs 22.9 (culture‐negative sepsis) vs 25.8 (culture‐positive groups) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐abdominal infection, bacterial pneumonia, urosepsis, cellulitis, puerperal sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (critical care and emergency medicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescent Access Immunoassay System (Beckman Coulter Inc, Brea, CA, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 64.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 (60.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 19.9 (sepsis) vs 15.9 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower respiratory tract infection, intra‐abdominal infection, bloodstream infection, and others </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IL‐6 EASIA test kit (Medgenics Diagnostics SA, Fleurus, Belgium)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Japan</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 66 to 76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 (58.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic and localized infection (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulyze 2000 assay system (Siemens Healthcare Diagnostics, Japan)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 43 to 46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 (51.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia in haematologic malignancies (neutropenia febrile)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Haematological malignancy with febrile neutropenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Roche Diagnostics Inc</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 56.7 vs 56.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116 (59.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis group only = APACHE II &gt; 25: 26.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Head/neck, thorax, abdomen, pelvic cavity, arms and legs, blood, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrochemical luminescence on a Roche COBAS‐e601</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115 (60.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (unclear) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMMULITE 1.000 System (Siemens)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean range: 51 to 59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57 (73.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory tract, intra‐abdominal space, bloodstream, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (unclear)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(ImmuliteOne; DPC Biermann, Bad Nauheim,<br/> Germany) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 58.3 (sepsis) vs 55.4 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 (61.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 18.2 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abdomen, thorax, and blood sources</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrochemical luminescence on a Roche COBAS‐e601</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>South Korea</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 51.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (49.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute pyelonephritis, pneumonia, digestive tract infection, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescence method using the Elecsys IL‐6 kit (Roche)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean range: 45.1 to 65.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61 (58.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gram‐negative bacterial sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biliary and intra‐abdominal infections</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 8.4 (SIRS) vs 9.3 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biliary infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BioLegend</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 59.47 (sepsis) vs 45.1 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (76.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 13.64 (SIRS) vs 19.37 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (critical care)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EK0410; Boster Biological Technology</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 60.6 (sepsis) vs 51.7 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (70.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 15.4 (sepsis) vs 7.9 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intraperitoneal infection, lower respiratory tract infection, lower respiratory tract infection complicated with haematogenous infection, intraperitoneal infection complicated with haematogenous infection, haematogenous infection and biliary tract infection </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Genzyme</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 65.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>126 (77.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory tract, abdomen, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (unclear) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Luminex LX200 using Invitrogen’s Human Inflammatory 5‐Plex panel (Invitrogen/Life Technologies, Darmstadt, Germany) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malaysia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>167 (69.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (critical care) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantikine enzyme‐linked immunosorbent assay kit from R&amp;D Systems (Minnesota, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐IV = 57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gastrointestinal, pulmonary, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMMULITE 2000; Siemens Healthcare, the Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 (37)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 12.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bloodstream, other sites</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ELISA kits (Genzyme, Cambridge, MA, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Range: 61 to 66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 (61.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ventilator‐associated pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients mechanically ventilated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐II: 18 (suspected VAP) vs 20 (confirmed VAP)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAP clinical criteria + BAL positive cultures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commercial enzimoimmunoassay technique (BioSource, Nivelles, Belgium)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (1 to 2 days at the day of diagnosis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2008</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>207 (63.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis/severe sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 15.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory system, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (critical care)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulite (DPC Biermann)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193 (56.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulite 2500 (Siemens Healthcare Diagnostics, Deerfield, IL, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (no details)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173 (51.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐II: 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lung, urinary tract, skin, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (emergency medicine or internal medicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Roche Elecsys 2010 analyser (Roche Diagnostics, Laval, Canada) by electro chemiluminescent immunoassay </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greece</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 59 (septic ARDS) vs 62.2 (non‐septic ARDS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (60)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis in acute respiratory distress syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ALI/ARDS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 24.3 (septic) vs 19.2 (non‐septic)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lung, bloodstream, skin‐soft tissue, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elecsys IL‐6 immunoassay (Roche Diagnostics GmbH, Mannheim, Germany)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 69 vs 73</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>357 (54.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ELISA (RapidBio Systems)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>ACCP</b> : American College of Chest Physicians;<b>ALI</b> : acute lung injury; <b>APACHE score:</b> Acute Physiology And Chronic Health Evaluation score; <b>ARDS</b> : acute respiratory distress syndrome; <b>ATS</b> : American Thoracic Society; <b>BAL</b> : bronchoalveolar lavage; <b>EASIA:</b> enzyme‐amplified sensitivity immunoassay; <b>ED:</b> emergency department; <b>EDTA</b> : ethylenediaminetetraacetic acid;<b>ELISA</b> : enzyme‐linked immunosorbent assay; <b>ESICM</b> : European Society of Intensive Care Medicine; <b>IL‐6</b> : interleukin‐6;<b>IL‐8</b> : interleukin‐8; <b>ICU</b> : intensive care unit <b>IQR</b> : interquartile range; <b>PCT</b> : procalcitonin; <b>SAPS</b> : Simplified Acute Physiology Score; <b>SCCM</b> : Society of Critical Care Medicine; <b>SIRS</b> : systemic inflammatory response syndrome; <b>SIS</b> : Surgical Infection Society; <b>VAP</b>: ventilator‐associated pneumonia. </p> </div> </div> <section id="CD011811-sec-0061"> <h5 class="title">General characteristics</h5> <p>We included a total of 23 studies and 4192 critically ill adults in the qualitative analysis. The sample size ranged from 20, in <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>, to 652 ill adults, in <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>. Mean sample size was 167.68 participants (interquartile range (IQR): 66 to 231). The included studies were published between 1994 and 2018. Most studies were published after the sepsis consensus of 2001, but before the release of the 2015 consensus criteria (16 studies; 69.5%; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). The three studies published after 2015 did not apply the updated definition (<a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>). A considerable number of studies were performed in Asia (12 studies; 52.1%), with China being the country with the most studies (8 studies; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). Nine studies were performed in Europe, and only two studies were conducted in the USA (<a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>). </p> <p>All studies provided information about participants with sepsis versus patients under suspicious of sepsis (i.e. SIRS adult patients). In addition, some studies provided data from healthy controls, but we did not include this information in the review. Four studies using the 2001 criteria provided additional information about sepsis versus SIRS plus organ dysfunction (<a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>), severe sepsis versus SIRS (<a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>), severe sepsis and shock versus SIRS (<a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>), and septic shock versus SIRS (<a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>). Most of the studies were funded by academic, governmental, or institutional sources (11 studies; 47.8%). Three studies were funded by medical device companies (<a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>), and three other studies stated that no funds were received for their development (<a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>). </p> </section> <section id="CD011811-sec-0062"> <h5 class="title">Population</h5> <p>The age of the participants was heterogeneously reported; seven studies reported mean age for all enrolled participants, ranging from 45.1 to 66 years (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>). The percentage of included men ranged from 37%, in <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>, to 77%, in <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>. The included studies reported multiple baseline diagnoses, with most studies only referring to their participants as ill patients, ICU patients, or patients with suspected sepsis (19 studies; 82.6%). Four studies were developed in specific populations, such as patients with acute respiratory distress syndrome (ARDS) (<a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>), biliary and intra‐abdominal infections (<a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>), haematological malignancies (<a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>), or mechanically ventilated patients (<a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>). Thirteen studies (56.5%) reported basal measurements of the Acute Physiology And Chronic Health Evaluation (APACHE‐II in most cases), with mean APACHE in septic groups ranging from 9.3 to 25.8 units. </p> <p>The origin of the infection was heterogeneous in the enrolled samples, and included acute pyelonephritis, pneumonia, digestive tract infection, intra‐abdominal infection, urosepsis, cellulitis, lower respiratory tract infections, urinary tract infections, and bloodstream infections, among others. The included studies did not provide subgroup information by source of infection. Four studies assessed bacteraemia (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>). One study focused its main analysis on the comparison between sepsis by culture findings (positive or negative) versus SIRS (<a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>). </p> <p>The most common setting was ICUs (mixed and surgical) (13 studies; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>). The remaining studies were set in emergency departments, with the exception of three studies for which the setting was unclear (<a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>). The use of empirical antibiotics was not explicitly stated or was unclear in 13 studies; in nine studies antibiotics were administered after blood sampling (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>). In one study, participants were excluded if they had received antimicrobial treatment for more than 24 hours before blood sampling (<a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>). </p> </section> <section id="CD011811-sec-0063"> <h5 class="title">Index test</h5> <p>All but five of the included studies, <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>, reported IL‐6 as the main test assessed. Fourteen studies used automated immunoassay analysers, and the remaining studies used enzyme‐linked immunosorbent assay (ELISA) kits (<a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). The methods/techniques used to read the results were absorbance/optical density (6 cases; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>); chemiluminescence (8 cases; <a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>); and electrochemiluminescence (6 cases; <a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>). </p> <p>The threshold of positivity for sepsis ranged from 40 pg/mL, in <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>, to 200,000 pg/mL, in <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>. Only one value (100 pg/mL) was reported by more than one study (<a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>). <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a> analysed the threshold of 200 pg/mL for sepsis versus SIRS and for sepsis versus SIRS with organ dysfunction. In addition, <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a> provided information about three different cut‐offs comparing sepsis versus SIRS patients (40, 100, and 500 pg/mL). No threshold was prespecified before statistical analysis (see <a href="./references#CD011811-sec-0098" title="">Characteristics of included studies</a>). <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a> also reported undetermined results for assessed groups; no additional studies reported these results. </p> </section> <section id="CD011811-sec-0064"> <h5 class="title">Reference standard</h5> <p>Ten studies used the 1991 ACCP/SCCM Consensus Conference Committee to define sepsis (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>; 40.9%; <a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>). In addition, six studies used the 2001 SCCM/ESICM/ACCP/ATS/SIS sepsis definition conference (27%; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). Sepsis was diagnosed by critical care, emergency, or internal medicine clinicians in five studies (<a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>), while this information was either unclear or not stated in the remaining studies. </p> <p>Sepsis prevalence ranged from 12.2%, in <a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>, to 77.9%, in <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>. In 12 studies the prevalence of sepsis was greater than 50% (<a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a>; <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). The median estimated prevalence was 47% (IQR: 37 to 69). </p> </section> </section> </section> <section id="CD011811-sec-0065"> <h3 class="title">Methodological quality of included studies</h3> <p>We appraised the quality of primary diagnostic accuracy studies using the QUADAS‐2 tool. The overall risk of bias and applicability concerns of the studies are summarized in <a href="#CD011811-fig-0002">Figure 2</a>. Quality assessment results for individual studies are presented in the <a href="./references#CD011811-sec-0098" title="">Characteristics of included studies</a> tables and in <a href="#CD011811-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011811-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies." data-id="CD011811-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. </p> </div> </div> </div> <div class="figure" id="CD011811-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD011811-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> </div> <p>Due to concerns related to the source of participants, we judged the risk of bias of patient selection (QUADAS‐2, domain 1) to be high in one study (<a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>). We considered eight trials to have an unclear risk of bias for this domain, mostly due to insufficient information related to the patient sampling (consecutive or random), as well as insufficient information about exclusions (<a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a>; <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>; <a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a>; <a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>). We considered the remaining 14 studies to be at low risk of bias. We had few concerns about applicability in most of the included trials. However, we had concerns about five studies that focused on specific populations, that is culture‐negative septic patients (<a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a>), intra‐abdominal infections (<a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>), ventilator‐associated pneumonia patients (<a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a>), a mix of cohorts of previous studies (<a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a>), or ARDS patients (<a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>). </p> <p>Regarding the index test assessment (QUADAS‐2, domain 2), we considered all studies to be at high risk of bias because none of them used a prespecified cut‐off to estimate sensitivity/specificity of IL‐6 (<a href="#CD011811-fig-0003">Figure 3</a>; <a href="#CD011811-fig-0002">Figure 2</a>). Likewise, most of the studies did not provide sufficient information to enable us to determine if index test results were interpreted without prior knowledge of the results of the reference standard. However, IL‐6 results were probably performed automatically and were thus not affected by additional information. We had minor concerns about the applicability of index tests in all of the included trials. </p> <p>We judged risk of bias due to conduct or interpretation of the reference standard(s) (QUADAS‐2, domain 3) to be unclear in eight studies (<a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a>; <a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a>; <a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a>; <a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a>; <a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a>; <a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a>). This was due to a lack of information about whether the reference standard results were interpreted with, or without, prior knowledge of the results of the IL‐6 measurements. We considered the risk to be low for the remaining 15 studies. We considered applicability of this domain to be low in all cases. </p> <p>Finally, with regard to the flow and timing assessment (QUADAS‐2, domain 4), we considered four studies to have an unclear risk of bias because there was insufficient information about the interval between IL‐6 measurement and the application of the reference standard, as well as the exclusion of participants from the final analysis of accuracy (<a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a>; <a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a>; <a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a>; <a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a>). </p> </section> <section id="CD011811-sec-0066"> <h3 class="title" id="CD011811-sec-0066">Findings</h3> <p>We included 21 studies collecting information from 1894 septic cases and 1756 non‐septic cases in the main analysis (<a href="#CD011811-fig-0004">Figure 4</a>). For this analysis, we excluded data for other comparisons provided by studies, including severe sepsis versus septic shock; severe sepsis versus SIRS; and shock versus SIRS. In addition, we selected one of the groups/thresholds reported by <a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a> (positive‐culture group) and by <a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a> (threshold of 100 pg/mL), since these groups were also found in other included studies. The range of sensitivities and specificities estimated by study, as well as the different thresholds proposed to define IL‐6 positive findings, are shown in <a href="#CD011811-fig-0004">Figure 4</a>. The SROC curve under the HSROC model, representing the accuracy of plasma IL‐6 thresholds used across studies, as well as individual study accuracy estimates, are shown in <a href="#CD011811-fig-0005">Figure 5</a>. Given the considerable variation in collected data shown by <a href="#CD011811-fig-0005">Figure 5</a>, and considering the heterogeneity of data described in the <a href="#CD011811-sec-0059">Results of the search</a> section, we refrained from calculating a formal sensitivity and specificity summary. </p> <div class="figure" id="CD011811-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of 1 Plasma interleukin‐6 concentrations." data-id="CD011811-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of 1 Plasma interleukin‐6 concentrations.</p> </div> </div> </div> <div class="figure" id="CD011811-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Summary receiver operating characteristic (SROC) plot of plasma interleukin‐6 concentrations, using hierarchical SROC parameters (estimated with SAS statistical software package)." data-id="CD011811-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of plasma interleukin‐6 concentrations, using hierarchical SROC parameters (estimated with SAS statistical software package). </p> </div> </div> </div> <p>We used the HSROC parameters to illustrate variations in sensitivity under a fixed specificity. Using a prevalence of sepsis of 50% and a fixed specificity of 74%, the estimated sensitivity was 66% (95% confidence interval (CI) 60 to 72). We noticed that 10 out of 21 individual studies included in this analysis reported sensitivities inferior or equal to this estimation. In terms of the possible consequences in a population of 1000 adult patients under suspicion of sepsis, this would translate into: </p> <p> <ul id="CD011811-list-0005"> <li> <p>330 out of 1000 patients would receive appropriate and timely antibiotic therapy;</p> </li> <li> <p>130 out of 1000 patients would be wrongly considered to have sepsis, and would receive unnecessary antibiotic therapy, with the added risk of resistance in a hospital setting, and may suffer delays in receiving appropriate treatment for their situation; </p> </li> <li> <p>370 out of 1000 patients would avoid unnecessary antibiotic therapy;</p> </li> <li> <p>170 out of 1000 patients would have undiagnosed sepsis and would be at serious risk of further morbidity and death due to delays of immediate antibiotic treatment. </p> </li> </ul> </p> <p>Additional estimations with prevalences of 12% and 78% (minimum and maximum values from included studies) show an increase in the number of false positives or false negative, respectively (<a href="./full#CD011811-tbl-0001">summary of findings Table</a>). </p> <section id="CD011811-sec-0067"> <h4 class="title">Investigation of heterogeneity</h4> <p>Due to the considerable variability of collected data, which prevented us from performing subgroup analysis (i.e. baseline diagnosis or origin of infection; see <a href="#CD011811-sec-0096">Differences between protocol and review</a>), we were not able to evaluate the potential effect of several sources of heterogeneity as initially planned. We were able to assess the effect of three covariates: year of publication (studies published in or after the year 2011; see <a href="#CD011811-sec-0096">Differences between protocol and review</a>), country/geographical area (studies conducted in Asia versus other settings) and setting (emergency versus ICU). We did not find statistical evidence of a difference in shape, test accuracy, or threshold parameters for models including country and setting as covariables. We found differences regarding shape and accuracy parameters according to publication year (Likelihood ratio test = 7.91; df = 2; P = 0.019). Approximately half of the studies published after 2011 showed specificities lower than 70%, while none of the studies published before 2011 showed specificities lower than 70% (<a href="#CD011811-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD011811-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Investigation of heterogeneity: year of publication (≥ 2011)." data-id="CD011811-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Investigation of heterogeneity: year of publication (≥ 2011).</p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011811-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011811-sec-0068"></div> <section id="CD011811-sec-0069"> <h3 class="title" id="CD011811-sec-0069">Summary of main results</h3> <p>We included 23 studies (4192 critically ill adult patients) assessing the accuracy of plasma IL‐6 concentrations for the diagnosis of sepsis. The included studies enrolled patients under suspicion of sepsis (i.e. SIRS patients), with further confirmation of sepsis, severe sepsis, septic shock, or no infection. The samples were heterogeneous in terms of their distribution of age, gender, main diagnosis, setting, country, positivity threshold, sepsis criteria, year of publication, and origin of infection, among other factors. In addition, the prevalence of sepsis reported in the included studies varied widely (from 12% to 78%; median: 47.3%). </p> <p>The main results of plasma IL‐6 concentration as a biomarker are provided in the <a href="./full#CD011811-tbl-0001">summary of findings Table</a>. This biomarker was assessed using a considerable number of thresholds that were not prespecified (from 40 to 200,000 pg/mL). We considered all studies to be at high risk of bias (QUADAS‐2/index test domain). The SROC curve showed a great dispersion in individual studies accuracy estimates (21 studies, 3650 adult participants), therefore the considerable heterogeneity in the collected data prevented us from calculating formal accuracy estimates. Using a fixed prevalence of sepsis of 50% and a fixed specificity of 74%, we found a sensitivity of 66% (95% CI 60 to 72). If we test a cohort of 1000 adult patients under suspicion of sepsis with IL‐6, we will find that 330 patients would receive appropriate and timely antibiotic therapy, while 130 patients would be wrongly considered to have sepsis. In addition, 370 out of 1000 patients would avoid unnecessary antibiotic therapy, and 170 patients would have been undiagnosed of sepsis. This numerical approach should be interpreted with caution due to the limitations described above. Due to the severe consequences of sepsis regarding its associated morbidity and mortality, we consider that the number of patients without adequate treatment, as a consequence of IL‐6 results, can be considered as unacceptable and deleterious for daily clinical management of this target condition (<a href="./full#CD011811-tbl-0001">summary of findings Table</a>). Heterogeneity of data was not fully explained for any of the covariates investigated within this review. </p> </section> <section id="CD011811-sec-0070"> <h3 class="title" id="CD011811-sec-0070">Strengths and weaknesses of the review</h3> <p>The strengths of this review include a comprehensive literature search performed to identify all relevant studies, a rigorous assessment of the risk of bias of included studies using the QUADAS‐2 tool, as well as duplicate data extraction. We did not impose restrictions on population characteristics such as age, site of infection, or setting. As a result, we found a highly heterogeneous body of evidence, with the included studies presenting differences in baseline diagnosis, origin of infection, reference standard applied, and prevalence of sepsis in their participants, among other factors. We tried to explore and quantify the possible sources of heterogeneity, but most of the assessed factors failed to explain the observed variability. Only one covariate (year of publication ≥ 2011) affected the accuracy and shape parameters of the HSROC model. We analysed this variable following the suggestions of the peer reviewers of the review, in order to assess if the most recent evidence reflects a better IL‐6 performance (<a href="#CD011811-sec-0096">Differences between protocol and review</a>). Approximately half of the studies published after 2011 showed specificities lower than 70%, while none of the studies published before 2011 showed specificities lower than 70%. This fact has an impact while evaluating differences in the shape of the curve by publication year. We cannot exclude that other factors, such as prevalence or sepsis criteria, are involved in this modification of effect. In addition, the sensitivity analyses planned in our protocol, <a href="./references#CD011811-bbs2-0185" title="Molano FrancoD , Arevalo‐RodriguezI , Roquéi Figuls M , ZamoraJ . Interleukin‐6 for diagnosis of sepsis in critically ill adult patients. Cochrane Database of Systematic Reviews2015, Issue 7. [DOI: 10.1002/14651858.CD011811] ">Molano Franco 2015</a>, based on the 'Risk of bias' assessments were made redundant by the serious risk of bias introduced by the threshold issues in the index test domain (See <a href="#CD011811-sec-0096">Differences between protocol and review</a>). Due to this high variability that was not fully explained, we refrained from calculating a summary sensitivity and specificity. </p> <p>Finally, we attempted to conduct a comprehensive search for studies, but the fact that a significant number of potentially eligible studies were only retrieved as conference proceedings may be considered as a source of potential bias. We expect that these studies will be fully published when our review is updated. </p> <section id="CD011811-sec-0071"> <h4 class="title">Agreements and disagreements with other studies or reviews</h4> <p>We identified three reviews assessing the accuracy of IL‐6 in the diagnosis of sepsis (<a href="./references#CD011811-bbs2-0137" title="HouT , HuangD , ZengR , YeZ , ZhangY . Accuracy of serum interleukin (IL)‐6 in sepsis diagnosis: a systematic review and meta‐analysis. International Journal of Clinical and Experimental Medicine2015;8(9):15238‐45. [PUBMED: 26629009] ">Hou 2015</a>; <a href="./references#CD011811-bbs2-0145" title="LiuY , HouJH , LiQ , ChenKJ , WangSN , WangJM . Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis. SpringerPlus2016;5(1):2091. [PUBMED: 28028489] ">Liu 2016</a>; <a href="./references#CD011811-bbs2-0147" title="MaL , ZhangH , YinYL , GuoWZ , MaYQ , WangYB , et al. Role of interleukin‐6 to differentiate sepsis from non‐infectious systemic inflammatory response syndrome. Cytokine2016;88:126‐35. [PUBMED: 27599258] ">Ma 2016</a>). Ma and colleagues collected and pooled the results of 20 studies assessing IL‐6 in sepsis (<a href="./references#CD011811-bbs2-0147" title="MaL , ZhangH , YinYL , GuoWZ , MaYQ , WangYB , et al. Role of interleukin‐6 to differentiate sepsis from non‐infectious systemic inflammatory response syndrome. Cytokine2016;88:126‐35. [PUBMED: 27599258] ">Ma 2016</a>), with cut‐off values of IL‐6 ranging between 18 and 423.5 pg/mL. The authors estimated a pooled sensitivity of 68% (95% CI 65% to 70%) and specificity of 73% (95% CI 71% to 76%) by means of a univariate model calculated by Meta‐DiSc 1.4 (<a href="./references#CD011811-bbs2-0184" title="ZamoraJ , AbrairaV , MurielA , KhanK , CoomarasamyA . Meta‐DiSc: a software for meta‐analysis of test accuracy data. BMC Medical Research Methodology2006;6:31. [PUBMED: 16836745] ">Zamora 2006</a>). Likewise, Hou and colleagues included six studies in their review, three of which were conducted in a paediatric population (<a href="./references#CD011811-bbs2-0137" title="HouT , HuangD , ZengR , YeZ , ZhangY . Accuracy of serum interleukin (IL)‐6 in sepsis diagnosis: a systematic review and meta‐analysis. International Journal of Clinical and Experimental Medicine2015;8(9):15238‐45. [PUBMED: 26629009] ">Hou 2015</a>). Analysing studies in an adult population under a random‐effects model (Littenberg and Moses method; <a href="./references#CD011811-bbs2-0144" title="LittenbergB , MosesLE . Estimating diagnostic accuracy from multiple conflicting reports: a new meta‐analytic method. Medical Decision Making: an International Journal of the Society for Medical Decision Making1993;13(4):313‐21. [PUBMED: 8246704] ">Littenberg 1993</a>; <a href="./references#CD011811-bbs2-0149" title="MosesLE , ShapiroD , LittenbergB . Combining independent studies of a diagnostic test into a summary ROC curve: data‐analytic approaches and some additional considerations. Statistics in Medicine1993;12(14):1293‐316. [PUBMED: 8210827] ">Moses 1993</a>), the estimated pooled sensitivity was 85% (95% CI 80% to 88%), and the estimated specificity was 62% (95% CI 55% to 68%). Cut‐off values in this review ranged between 40 and 145 pg/mL, and risk of bias was not assessed. Finally, Liu and colleagues identified 22 studies addressing the accuracy of IL‐6 with a median cut‐off of 138 pg/mL (ranging from 75 to 220 pg/mL) (<a href="./references#CD011811-bbs2-0145" title="LiuY , HouJH , LiQ , ChenKJ , WangSN , WangJM . Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis. SpringerPlus2016;5(1):2091. [PUBMED: 28028489] ">Liu 2016</a>). Using a bivariate mixed‐effects regression model, the authors estimated a pooled sensitivity of 72% (95% CI 63% to 80%) and specificity of 73% (95% CI 67% to 79%). Risk of bias assessed with QUADAS‐1 was affected for issues related to blinding of test and reference standard results, as well as uninterpretable results. </p> <p>Compared with our review, these studies used a different set of criteria to select eligible references, such as case‐control studies, paediatric populations, and data about prediction of sepsis, as well as alternative statistical approaches to analyse the collected information. In addition, two out of the three reviews mentioned used QUADAS‐1 or no assessment of the methodological quality for eligible studies. In our review, we refrained from calculating a summary sensitivity and specificity due to the considerable variation in the collected data. Due to this variability, especially that generated by threshold variations, only an HSROC approach is recommendable to analyse the gathered data (<a href="./references#CD011811-bbs2-0123" title="DeeksJJ , BossuytPM , GatsonisC (editors) . Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org. ">Deeks 2013</a>). </p> <p>We also noticed that the three identified reviews warn about significant heterogeneity among included studies, mostly guided by information provided by I<sup>2</sup> statistics, but only <a href="./references#CD011811-bbs2-0145" title="LiuY , HouJH , LiQ , ChenKJ , WangSN , WangJM . Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis. SpringerPlus2016;5(1):2091. [PUBMED: 28028489] ">Liu 2016</a> and <a href="./references#CD011811-bbs2-0147" title="MaL , ZhangH , YinYL , GuoWZ , MaYQ , WangYB , et al. Role of interleukin‐6 to differentiate sepsis from non‐infectious systemic inflammatory response syndrome. Cytokine2016;88:126‐35. [PUBMED: 27599258] ">Ma 2016</a> investigated their effects through a formal statistical method (meta‐regression analysis; no further details provided). Liu and colleagues analysed six potential sources of heterogeneity, including publication year, age of patients, prevalence, and methodological quality (<a href="./references#CD011811-bbs2-0145" title="LiuY , HouJH , LiQ , ChenKJ , WangSN , WangJM . Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis. SpringerPlus2016;5(1):2091. [PUBMED: 28028489] ">Liu 2016</a>). Likewise, Ma and colleagues analysed the effect of seven factors (<a href="./references#CD011811-bbs2-0147" title="MaL , ZhangH , YinYL , GuoWZ , MaYQ , WangYB , et al. Role of interleukin‐6 to differentiate sepsis from non‐infectious systemic inflammatory response syndrome. Cytokine2016;88:126‐35. [PUBMED: 27599258] ">Ma 2016</a>), finding that admission category, setting, and reference standard make a significant contribution in explaining data variability. In our review, using an HSROC approach in the analysis of sources of heterogeneity, we were unable to fully explain the heterogeneity of data using a number of prespecified covariates. </p> </section> </section> <section id="CD011811-sec-0072"> <h3 class="title" id="CD011811-sec-0072">Applicability of findings to the review question</h3> <p>Our findings show the complexity of the study of sepsis in critically ill patients, as well as the multiplicity of factors involved in the adequate diagnosis of this life‐threatening dysfunction. Due to its close relationship with inflammatory processes, plasma interleukin‐6 has been proposed as a potentially useful test to identify critical patients while microbiological confirmation is achieved. However, we found several limitations in translating these results into clinical practice. </p> <p>One of the major issues that limits the applicability of findings to the review question is the considerable heterogeneity in the gathered evidence, which was a major constraint in our statistical analysis. The effect of some critical covariates, such as baseline diagnosis, cut‐off value for positivity, origin of infection, and reference standard, cannot be fully analysed by the methods stated in our protocol. This substantial variability in sepsis research was previously noticed by Singer and colleagues (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). The authors of the Sepsis‐3 consensus stated that the lack of a validated standard clinical criterion in this field led to important discrepancies in the estimation of sepsis incidence and related mortality (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). Currently, there are agreements about the need to redefine or to abandon some terms (i.e. severe sepsis), as well as the lack of clinical significance of extended‐use criteria for the diagnosis of sepsis (i.e. two or more SIRS criteria). None of the novel biomarkers suggested for the diagnosis of sepsis were formally included in the Sepsis‐3 criteria, due to the fact that they “require broader validation before they can be incorporated into the clinical criteria describing sepsis” (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> <p>In the critical care setting, the use of biomarkers has other well‐known limitations such as the associated costs, limited availability in low/middle‐income settings, and the lack of experience of clinicians in its use. Our findings do not suggest that the accuracy of this biomarker is sufficient enough to assure the role of this test in the current clinical sepsis pathway. At present, the role of IL‐6, as well as other biomarkers, is being assessed in the prediction of severe outcomes (i.e. organ failure and mortality), under a prognostic approach (<a href="./references#CD011811-bbs2-0148" title="McGuireTR , ReardonNT , BogardK , PlumbTJ , BultsmaCJ , NissenSW , et al. IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: a predictor for survival. In Vivo2014;28(6):1131‐4. [PUBMED: 25398811] ">McGuire 2014</a>; <a href="./references#CD011811-bbs2-0151" title="Pallas BeneytoLA , Rodriguez LuisO , Saiz SanchezC , Cotell SimonO , Bautista RenteroD , Miguel BayarriV . Prognostic value of interleukin 6 for death of patients with sepsis [Valor pronostico de la interleucina 6 en la mortalidad de pacientes con sepsis]. Medicina Clinica2016;147(7):281‐6. [PUBMED: 27422737] ">Pallas 2016</a>; <a href="./references#CD011811-bbs2-0162" title="Rios‐ToroJJ , Marquez‐CoelloM , Garcia‐AlvarezJM , Martin‐AspasA , Rivera‐FernandezR , Saez de BenitoA , et al. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLOS ONE2017;12(4):e0175254. [PUBMED: 28380034] ">Rios‐Toro 2017</a>; <a href="./references#CD011811-bbs2-0171" title="StoppelkampS , VeseliK , StangK , SchlensakC , WendelHP , WalkerT . Identification of predictive early biomarkers for sterile‐SIRS after cardiovascular surgery. PLOS ONE2015;10(8):e0135527. [PUBMED: 26263001] ">Stoppelkamp 2015</a>; <a href="./references#CD011811-bbs2-0183" title="WongHR , WalleyKR , PettilaV , MeyerNJ , RussellJA , KarlssonS , et al. Comparing the prognostic performance of ASSIST to interleukin‐6 and procalcitonin in patients with severe sepsis or septic shock. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals2015;20(2):132‐5. [PUBMED: 25578228] ">Wong 2015</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011811-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011811-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies." data-id="CD011811-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD011811-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of 1 Plasma interleukin‐6 concentrations." data-id="CD011811-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of 1 Plasma interleukin‐6 concentrations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Summary receiver operating characteristic (SROC) plot of plasma interleukin‐6 concentrations, using hierarchical SROC parameters (estimated with SAS statistical software package)." data-id="CD011811-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of plasma interleukin‐6 concentrations, using hierarchical SROC parameters (estimated with SAS statistical software package). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Investigation of heterogeneity: year of publication (≥ 2011)." data-id="CD011811-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Investigation of heterogeneity: year of publication (≥ 2011).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011811-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/urn:x-wiley:14651858:media:CD011811:CD011811-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_t/tCD011811-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="Plasma interleukin‐6 concentrations." data-id="CD011811-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>Plasma interleukin‐6 concentrations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/references#CD011811-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/media/CDSR/CD011811/image_n/nCD011811-TST-001.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011811-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Plasma interleukin‐6 concentration for diagnosis of sepsis in critically ill adults</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Critically ill adults under suspicion of sepsis (i.e. with SIRS symptoms)</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Prior testing</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Physical examination and history</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Index test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Plasma interleukin‐6, measured before antibiotic treatment. Cut‐off for positivity ranged from 40 to 200,000 pg/mL. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Role of the test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Triage: First test for patients with SIRS symptoms and waiting for further results (i.e. culture) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>Intensive care units, emergency departments, institutional setting (no details provided)</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p>3 sepsis definitions derived from expert consensus were considered valid reference standards: </p> <p> <ul id="CD011811-list-0001"> <li> <p>1991 ACCP/SCCM Consensus Conference (<a href="./references#CD011811-bbs2-0114" title="BoneRC , BalkRA , CerraFB , DellingerRP , FeinAM , KnausWA , et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101(6):1644‐55. [PUBMED: 1303622] ">Bone 1992</a>); </p> </li> <li> <p>2001 SCCM/ESICM/ACCP/ATS/SIS consensus (<a href="./references#CD011811-bbs2-0142" title="LevyMM , FinkMP , MarshallJC , AbrahamE , AngusD , CookD , et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine2003;31(4):1250‐6. [PUBMED: 12682500] ">Levy 2003</a>); </p> </li> <li> <p>2015 ESICM/SCCM consensus (<a href="./references#CD011811-bbs2-0169" title="SingerM , DeutschmanCS , SeymourCW , Shankar‐HariM , AnnaneD , BauerM , et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA2016;315(8):801‐10. [PUBMED: 26903338] ">Singer 2016</a>). </p> </li> </ul> </p> <p>Sepsis criteria were applied by critical care, emergency, or internal medicine clinicians.</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Index test</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Prevalence</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (under fixed specificity)<sup>1</sup> </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (fixed)<sup>2</sup> </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of false positives out of 1000 patients</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of false negatives out of 1000 patients</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Plasma interleukin‐6 concentration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>3650</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>66% (95% confidence interval 60 to 72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>74%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>229</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>High heterogeneity of collected evidence remains a significant constraint for plasma interleukin‐6 implementation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>1</sup>HSROC (hierarchical summary receiver operating characteristic) parameters were used to illustrate sensitivity for a fixed specificity.<br/> <sup>2</sup>Median specificity estimated from included studies. </p> <p><b>Abbreviations: AB</b> : antibiotic; <b>ACCP</b> : American College of Chest Physicians; <b>ATS</b> : American Thoracic Society; <b>ESICM</b> : European Society of Intensive Care Medicine; <b>QUADAS</b> : Quality Assessment of Diagnostic Accuracy Studies; <b>SCCM</b> : Society of Critical Care Medicine; <b>SIRS</b> : systemic inflammatory response syndrome; <b>SIS</b>: Surgical Infection Society. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Plasma interleukin‐6 concentration for diagnosis of sepsis in critically ill adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011811-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year of publication</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age (as reported)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b># Male (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>APACHE (as reported)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Origin of infection</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IL‐6 measurement brand</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Use of empirical antibiotics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Funding</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0001" title="AaltoH , TakalaA , KautiainenH , RepoH . Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. European Journal of Clinical Microbiology and Infectious Diseases2004;23(9):699‐704. [PUBMED: 15309668] ">Aalto 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2004</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Finland</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 (47.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐acquired bloodstream infection with positive blood cultures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia, urinary tract infection, encephalitis and meningitis, abscesses, sinusitis, malaria, erysipelas </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescent immunoassay system (Immulite; Diagnostic Products, Los Angeles, CA, USA) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0002" title="AnandD , DasS , BhargavaS , SrivastavaLM , GargA , TyagiN , et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture‐negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Journal of Critical Care2015;30(1):218.e7‐12. [PUBMED: 25263339] ">Anand 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 42 (culture‐negative sepsis) vs 53.7 (culture‐positive sepsis) vs 54 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 (58.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture‐negative/positive bacterial sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 15.9 (SIRS) vs 22.9 (culture‐negative sepsis) vs 25.8 (culture‐positive groups) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐abdominal infection, bacterial pneumonia, urosepsis, cellulitis, puerperal sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (critical care and emergency medicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescent Access Immunoassay System (Beckman Coulter Inc, Brea, CA, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0003" title="DuB , LiY , ChenD , PanJ . Serum procalcitonin and interleukin‐6 help differentiate between severe sepsis and systemic inflammatory response syndrome of non‐infectious origin. Zhonghua Yi Xue Za Zhi2002;82(16):1111‐4. [PUBMED: 12425821] DuB , PanJ , ChenD , LiY . Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chinese Medical Journal2003;116(4):538‐42. [PUBMED: 12875718] ">Du 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 64.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 (60.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 19.9 (sepsis) vs 15.9 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower respiratory tract infection, intra‐abdominal infection, bloodstream infection, and others </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IL‐6 EASIA test kit (Medgenics Diagnostics SA, Fleurus, Belgium)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0004" title="EndoS , SuzukiY , TakahashiG , ShozushimaT , IshikuraH , MuraiA , et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy2012;18(6):891‐7. [PUBMED: 22692596] ">Endo 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Japan</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 66 to 76</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 (58.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic and localized infection (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulyze 2000 assay system (Siemens Healthcare Diagnostics, Japan)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0005" title="FuY , ChenJ , CaiB , ZhangJ , LiL , WangL . Serum procalcitonin, interleukin‐6, C‐reactive protein and serum amyloid a measurement in ICU department for diagnostic evaluation and risk‐analysis of prolonged ICU stay in patients with sepsis. Clinical Chemistry2013;59(10 Suppl 1):A199. [Embase: 72249200] FuY , ChenJ , CaiB , ZhangJL , LiLX , WangLL . Diagnostic values of procalcitonin, interleukin‐6, C reactive protein and serum amyloid A in sepsis. Sichuan da Xue Xue Bao Yi Xue Ban2012;43(5):702‐5. [PUBMED: 23230743] FuY , ChenJ , LiL , WangL . The usefulness of procalcitonin (PCT), interleukin‐6 (IL‐6), C reactive protein (CRP) and serum amyloid protein a (SAA) in diagnosis of nonviral infection of liver/kidney transplanted patients. Transplant International2013;26 Suppl 2:165. FuY , JiangH , LiL , ChenJ , ZhangJL , WangLL . Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi2013;21(5):1296‐300. [PUBMED: 24156453] ">Fu 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 43 to 46</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 (51.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia in haematologic malignancies (neutropenia febrile)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Haematological malignancy with febrile neutropenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Roche Diagnostics Inc</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0006" title="GaoL , YangB , ZhangH , OuQ , LinY , ZhangM , et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget2018;9(13):10934‐44. [PUBMED: 29541387] ">Gao 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2018</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 56.7 vs 56.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116 (59.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis group only = APACHE II &gt; 25: 26.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Head/neck, thorax, abdomen, pelvic cavity, arms and legs, blood, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrochemical luminescence on a Roche COBAS‐e601</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0007" title="GomezJA , Ortiz‐EspejoM , Torrealba‐RodríguezMI , Gordillo‐ÁlvarezJ , Castellanos‐OrtegaA , SuberviolaB , et al. Evaluation of the diagnostic and prognostic capacity of procalcitonin, C reactive protein, interleukin‐6 and lipopolysaccharide binding protein in patients suspected of having sepsis [Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina‐6 y proteína ligadora del lipopolisacárido en pacientes con sospecha de sepsis]. Revista del Laboratorio Clinico2010;3(1):12‐9. [ibc‐85192] ">Gomez 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115 (60.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (unclear) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMMULITE 1.000 System (Siemens)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0008" title="HarbarthS , HoleckovaK , FroidevauxC , PittetD , RicouB , GrauGE , et al. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine2001;164(3):396‐402. [PUBMED: 11500339] ">Harbarth 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean range: 51 to 59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57 (73.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory tract, intra‐abdominal space, bloodstream, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (unclear)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(ImmuliteOne; DPC Biermann, Bad Nauheim,<br/> Germany) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0009" title="HouYQ , LiangDY , LouXL , ZhangM , ZhangZH , ZhangLR . Branched DNA‐based Alu quantitative assay for cell‐free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. Journal of Critical Care2016;31(1):90‐5. [PUBMED: 26589770] ">Hou 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 58.3 (sepsis) vs 55.4 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 (61.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 18.2 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abdomen, thorax, and blood sources</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrochemical luminescence on a Roche COBAS‐e601</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0010" title="JekarlDW , KimJY , LeeS , KimM , KimY , HanK , et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clinical Chemistry and Laboratory Medicine2015;53(4):575‐81. [PUBMED: 25274957] JekarlDW , LeeSY , LeeJ , ParkYJ , KimY , ParkJH , et al. Procalcitonin as a diagnostic marker and IL‐6 as a prognostic marker for sepsis. Diagnostic Microbiology and Infectious Disease2013;75(4):342‐7. [PUBMED: 23391607] ">Jekarl 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>South Korea</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 51.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (49.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute pyelonephritis, pneumonia, digestive tract infection, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chemiluminescence method using the Elecsys IL‐6 kit (Roche)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0011" title="JiangYN , CaiX , ZhouHM , JinWD , ZhangM , ZhangY , et al. Diagnostic and prognostic roles of soluble CD22 in patients with Gram‐negative bacterial sepsis. Hepatobiliary and Pancreatic Diseases International2015;14(5):523‐9. [PUBMED: 26459729] ">Jiang 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2015</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean range: 45.1 to 65.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61 (58.6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gram‐negative bacterial sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biliary and intra‐abdominal infections</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 8.4 (SIRS) vs 9.3 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biliary infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BioLegend</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0012" title="LiL , ZhuZ , ChenJ , OuyangB , ChenM , GuanX . Diagnostic value of soluble triggering receptor expressed on myeloid cells‐1 in critically‐ill, postoperative patients with suspected sepsis. American Journal of the Medical Sciences2013;345(3):178‐84. [PUBMED: 22739556] ">Li 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 59.47 (sepsis) vs 45.1 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (76.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 13.64 (SIRS) vs 19.37 (sepsis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (critical care)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EK0410; Boster Biological Technology</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0013" title="LiuXL , DuB , PanJQ , XuY , HuaBL . Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2005;27(1):48‐52. [PUBMED: 15782493] ">Liu 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 60.6 (sepsis) vs 51.7 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (70.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II = 15.4 (sepsis) vs 7.9 (SIRS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intraperitoneal infection, lower respiratory tract infection, lower respiratory tract infection complicated with haematogenous infection, intraperitoneal infection complicated with haematogenous infection, haematogenous infection and biliary tract infection </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Genzyme</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0014" title="LlewelynMJ , BergerM , GregoryM , RamaiahR , TaylorAL , CurdtI , et al. Sepsis biomarkers in unselected patients on admission to intensive or high‐dependency care. Critical Care2013;17(2):R60. [PUBMED: 23531337] ">Llewelyn 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>United Kingdom</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 65.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>126 (77.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory tract, abdomen, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (unclear) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Luminex LX200 using Invitrogen’s Human Inflammatory 5‐Plex panel (Invitrogen/Life Technologies, Darmstadt, Germany) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0015" title="Mat‐NorMB , RalibAMD , AbdulahNZ , PickeringJW . The diagnostic ability of procalcitonin and interleukin‐6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Journal of Critical Care2016;33:245‐51. [PUBMED: 26851139] ">Mat‐Nor 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malaysia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>167 (69.8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ applied for clinicians (critical care) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantikine enzyme‐linked immunosorbent assay kit from R&amp;D Systems (Minnesota, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0016" title="MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il‐6, or LBP. Critical Care Research and Practice2011;2011:594645. [PUBMED: 21687569] MeynaarIA , DroogW , BatstraM , VreedeR , HerbrinkP . Procalcitonin is more useful in diagnosing sepsis than CRP, IL‐6 and LBP. Intensive Care Medicine2010;36 Suppl 2:S134. ">Meynaar 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐IV = 57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gastrointestinal, pulmonary, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IMMULITE 2000; Siemens Healthcare, the Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Industry</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0017" title="MoscovitzH , ShoferF , MignottH , BehrmanA , KilpatrickL . Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Critical Care Medicine1994;22(7):1102‐7. [PUBMED: 8026198] ">Moscovitz 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1994</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 (37)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 12.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bloodstream, other sites</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ELISA kits (Genzyme, Cambridge, MA, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (after sampling)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0018" title="RamirezP , FerrerM , GimenoR , TormoS , ValenciaM , PinerR , et al. Systemic inflammatory response and increased risk for ventilator‐associated pneumonia: a preliminary study. Critical Care Medicine2009;37(5):1691‐5. [PUBMED: 19325465] ">Ramirez 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Range: 61 to 66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 (61.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ventilator‐associated pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients mechanically ventilated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐II: 18 (suspected VAP) vs 20 (confirmed VAP)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAP clinical criteria + BAL positive cultures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commercial enzimoimmunoassay technique (BioSource, Nivelles, Belgium)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (1 to 2 days at the day of diagnosis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0019" title="SakrY , BurgettU , NaculFE , ReinhartK , BrunkhorstF . Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Critical Care Medicine2008;36(7):2014‐22. [PUBMED: 18552695 ] ">Sakr 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2008</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>207 (63.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis/severe sepsis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 15.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Respiratory system, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (critical care)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulite (DPC Biermann)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0020" title="TrompM , LansdorpB , Bleeker‐RoversCP , GunnewiekJM , KullbergBJ , PickkersP . Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. Journal of Infection2012;65(4):292‐301. [PUBMED: 22710263] ">Tromp 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Netherlands</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193 (56.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bacteraemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIRS criteria + microbiological evidence of local infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immulite 2500 (Siemens Healthcare Diagnostics, Deerfield, IL, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (no details)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0021" title="TsalikEL , JaggersLB , GlickmanSW , LangleyRJ , vanVelkinburghJC , ParkLP , et al. Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine2012;43(1):97‐106. [PUBMED: 22056545] ">Tsalik 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173 (51.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median APACHE‐II: 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lung, urinary tract, skin, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 ACCP/SCCM Consensus Conference Committee ‐ applied for clinicians (emergency medicine or internal medicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Roche Elecsys 2010 analyser (Roche Diagnostics, Laval, Canada) by electro chemiluminescent immunoassay </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Academic/ governmental/ health agency</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0022" title="TsantesA , TsangarisI , KopteridesP , KapsimaliV , AntonakosG , ZervaA , et al. The role of procalcitonin and IL‐6 in discriminating between septic and non‐septic causes of ALI/ARDS: a prospective observational study. Clinical Chemistry and Laboratory Medicine2013;51(7):1535‐42. [PUBMED: 23314554] ">Tsantes 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greece</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 59 (septic ARDS) vs 62.2 (non‐septic ARDS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (60)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis in acute respiratory distress syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ALI/ARDS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean APACHE‐II: 24.3 (septic) vs 19.2 (non‐septic)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lung, bloodstream, skin‐soft tissue, others</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elecsys IL‐6 immunoassay (Roche Diagnostics GmbH, Mannheim, Germany)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No funding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011811-bbs2-0023" title="ZhaoY , LiC . Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2014;26(3):153‐8. [PUBMED: 24598287] ">Zhao 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2014</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 69 vs 73</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>357 (54.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sepsis (general)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mix/unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2001 SCCM/ESICM/ACCP/ATS/ SIS sepsis definition conference ‐ no further details provided</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ELISA (RapidBio Systems)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="14"> <div class="table-footnote"> <p><b>ACCP</b> : American College of Chest Physicians;<b>ALI</b> : acute lung injury; <b>APACHE score:</b> Acute Physiology And Chronic Health Evaluation score; <b>ARDS</b> : acute respiratory distress syndrome; <b>ATS</b> : American Thoracic Society; <b>BAL</b> : bronchoalveolar lavage; <b>EASIA:</b> enzyme‐amplified sensitivity immunoassay; <b>ED:</b> emergency department; <b>EDTA</b> : ethylenediaminetetraacetic acid;<b>ELISA</b> : enzyme‐linked immunosorbent assay; <b>ESICM</b> : European Society of Intensive Care Medicine; <b>IL‐6</b> : interleukin‐6;<b>IL‐8</b> : interleukin‐8; <b>ICU</b> : intensive care unit <b>IQR</b> : interquartile range; <b>PCT</b> : procalcitonin; <b>SAPS</b> : Simplified Acute Physiology Score; <b>SCCM</b> : Society of Critical Care Medicine; <b>SIRS</b> : systemic inflammatory response syndrome; <b>SIS</b> : Surgical Infection Society; <b>VAP</b>: ventilator‐associated pneumonia. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/full#CD011811-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011811-tbl-0003"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 Plasma interleukin‐6 concentrations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3650</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011811.pub2/references#CD011811-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011811.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011811-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011811-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011811-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011811-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD011811-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011811-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011811\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011811\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011811\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011811\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011811\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011811.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011811.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011811.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011811.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011811.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718399109"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011811.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718399112"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011811.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcf61baa4935f',t:'MTc0MDcxODM5OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 